phytochemical cluster No. 1 (164 metabolites)
Plant Species
Cumulative plant class count
| class name | count |
|---|---|
| asterids | 518 |
| rosids | 240 |
| eudicotyledons | 27 |
| Liliopsida | 26 |
| Magnoliophyta | 26 |
| Spermatophyta | 4 |
| Euphyllophyta | 2 |
| Embryophyta | 1 |
Cumulative family count (Top 20)
| class name | count |
|---|---|
Solanaceae
|
345 |
|
Fabaceae
|
141 |
|
Convolvulaceae
|
116 |
|
Erythroxylaceae
|
32 |
|
Piperaceae
|
23 |
|
Lamiaceae
|
17 |
|
Proteaceae
|
17 |
|
Campanulaceae
|
17 |
|
Rhizophoraceae
|
16 |
|
Brassicaceae
|
10 |
|
Capparaceae
|
8 |
|
Asteraceae
|
6 |
|
Arecaceae
|
6 |
|
Cornaceae
|
5 |
|
Hyacinthaceae
|
5 |
|
Xanthorrhoeaceae
|
5 |
|
Moraceae
|
5 |
|
Crassulaceae
|
5 |
|
Euphorbiaceae
|
5 |
|
Connaraceae
|
4 |
KEGG BRITE br08003
Categories (5)
| br08003 Category | # of metabolite |
|---|---|
| Pyridine alkaloids | 16 |
| Piperidine alkaloids | 29 |
| Pyrrolidine alkaloids | 6 |
| Acetate derived alkaloids | 4 |
| Tropane alkaloids | 34 |
metabolites link (90)
KCF-S cluster (59)
| KCF-S ID | # of metabolite |
|---|---|
| No. 666 | 13 |
| No. 643 | 13 |
| No. 786 | 11 |
| No. 1355 | 7 |
| No. 1464 | 7 |
| No. 1523 | 7 |
| No. 1640 | 6 |
| No. 1887 | 6 |
| No. 2084 | 5 |
| No. 2708 | 4 |
| No. 2627 | 4 |
| No. 2519 | 4 |
| No. 2560 | 4 |
| No. 2640 | 4 |
| No. 3149 | 3 |
| No. 3916 | 3 |
| No. 4269 | 3 |
| No. 4208 | 3 |
| No. 2565 | 3 |
| No. 3405 | 3 |
| No. 3195 | 3 |
| No. 1656 | 3 |
| No. 3745 | 3 |
| No. 4209 | 3 |
| No. 5088 | 2 |
| No. 4784 | 2 |
| No. 5493 | 2 |
| No. 3681 | 2 |
| No. 6807 | 1 |
| No. 6790 | 1 |
| No. 6821 | 1 |
| No. 6249 | 1 |
| No. 8065 | 1 |
| No. 7456 | 1 |
| No. 7534 | 1 |
| No. 7832 | 1 |
| No. 7059 | 1 |
| No. 8621 | 1 |
| No. 8522 | 1 |
| No. 8034 | 1 |
| No. 7267 | 1 |
| No. 8495 | 1 |
| No. 7995 | 1 |
| No. 5785 | 1 |
| No. 5352 | 1 |
| No. 6365 | 1 |
| No. 4967 | 1 |
| No. 6575 | 1 |
| No. 6292 | 1 |
| No. 5790 | 1 |
| No. 6567 | 1 |
| No. 6005 | 1 |
| No. 8310 | 1 |
| No. 6694 | 1 |
| No. 8771 | 1 |
| No. 8391 | 1 |
| No. 8036 | 1 |
| No. 8949 | 1 |
| No. 5263 | 1 |
Metabolite list (164)
Human Protein / Gene in interactions
231 ChEMBL Protein in interactions
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000208 C00000209 C00001343 C00001345 C00001388 C00002015 C00002020 C00002035 C00002043 C00002051 C00002053 C00002056 C00002057 C00002065 C00002066 C00002069 C00002074 C00002277 C00002287 C00002292 C00002293 C00002298 C00002300 C00002301 C00002306 C00029420 C00036384 | 1 / 0 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000208 C00000209 C00001343 C00001345 C00001388 C00002015 C00002020 C00002035 C00002043 C00002051 C00002053 C00002056 C00002057 C00002065 C00002066 C00002069 C00002074 C00002277 C00002287 C00002292 C00002293 C00002298 C00002300 C00002301 C00002306 C00029420 C00036384 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000208 C00000209 C00001343 C00001345 C00001388 C00002015 C00002020 C00002035 C00002043 C00002051 C00002053 C00002056 C00002057 C00002065 C00002066 C00002069 C00002074 C00002277 C00002287 C00002292 C00002293 C00002298 C00002300 C00002301 C00002306 C00029420 C00036384 | 1 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000208 C00000209 C00001343 C00001345 C00001388 C00002015 C00002020 C00002035 C00002043 C00002051 C00002053 C00002056 C00002057 C00002065 C00002066 C00002069 C00002074 C00002277 C00002287 C00002292 C00002293 C00002298 C00002300 C00002301 C00002306 C00029420 C00036384 | 0 / 1 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000208 C00000209 C00001343 C00001345 C00001388 C00002015 C00002020 C00002035 C00002043 C00002051 C00002053 C00002056 C00002057 C00002065 C00002066 C00002069 C00002074 C00002277 C00002287 C00002292 C00002293 C00002298 C00002300 C00002301 C00002306 C00029420 C00036384 | 0 / 1 |
| P02545 | Prelamin-A/C | Unclassified protein | C00001343 C00001345 C00001388 C00002020 C00002053 C00002057 C00002065 C00002066 C00002069 C00002277 C00002292 C00002293 C00002301 C00002306 C00007256 | 11 / 10 |
| O75496 | Geminin | Unclassified protein | C00000209 C00002053 C00002057 C00002066 C00002069 C00002277 C00002280 C00002285 C00002288 C00002293 C00002298 C00036384 | 0 / 0 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000208 C00000209 C00002020 C00002057 C00002277 C00002292 C00002293 C00025551 C00025556 C00037122 C00044191 | 1 / 0 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000208 C00000209 C00002020 C00002057 C00002277 C00002292 C00002293 C00025551 C00025556 C00037122 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000208 C00000209 C00002020 C00002057 C00002277 C00002292 C00002293 C00025551 C00025556 C00037122 | 0 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000208 C00000209 C00002020 C00002057 C00002277 C00002292 C00002293 C00025551 C00025556 C00037122 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000208 C00000209 C00002020 C00002057 C00002277 C00002292 C00002293 C00025551 C00025556 C00037122 | 0 / 0 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00000208 C00002035 C00002042 C00002056 C00002057 C00002058 C00002065 C00002066 C00029420 C00037055 | 0 / 0 |
| P04062 | Glucosylceramidase | Enzyme | C00002035 C00002038 C00002283 C00029420 C00035552 C00036384 C00036866 C00049941 C00049947 | 6 / 4 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002043 C00002053 C00002057 C00002061 C00002277 C00002292 C00002293 C00036930 C00042792 | 0 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00002065 C00002066 C00002069 C00002277 C00002280 C00002286 C00002293 C00036930 | 0 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00000208 C00000209 C00002057 C00002065 C00002066 C00002277 C00002293 C00002300 | 0 / 0 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002015 C00002035 C00002074 C00002277 C00002293 C00002298 C00029420 C00036930 | 1 / 2 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000208 C00000209 C00002035 C00002043 C00002057 C00002277 C00002293 C00029420 | 0 / 0 |
| O00255 | Menin | Unclassified protein | C00002015 C00002035 C00002074 C00002277 C00002293 C00029420 C00036930 | 2 / 5 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000208 C00000209 C00000210 C00001387 C00002057 C00002277 C00002293 | 0 / 3 |
| P17787 | Neuronal acetylcholine receptor subunit beta-2 | CHRN beta | C00002015 C00002053 C00002057 C00002061 C00002305 C00025552 C00042792 | 1 / 1 |
| P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00002015 C00002053 C00002057 C00002061 C00002305 C00025552 C00042792 | 0 / 0 |
| P43681 | Neuronal acetylcholine receptor subunit alpha-4 | CHRN alpha | C00002015 C00002053 C00002057 C00002061 C00002305 C00025552 C00042792 | 1 / 1 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000208 C00000209 C00002057 C00002277 C00002280 C00002285 C00002293 | 2 / 2 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002065 C00002066 C00002277 C00002280 C00002285 C00002293 C00007256 | 0 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00000209 C00002057 C00002074 C00002277 C00002293 C00007256 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00002057 C00002066 C00002069 C00002285 C00002302 C00037055 | 4 / 3 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00000208 C00002035 C00002038 C00029420 C00049941 C00049947 | 1 / 1 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00000208 C00000209 C00002053 C00002057 C00002277 C00002293 | 0 / 0 |
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00001388 C00002020 C00002057 C00002058 C00002277 C00002293 | 0 / 1 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001555 C00002043 C00002057 C00002069 C00002280 C00002300 | 0 / 0 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000208 C00000209 C00002057 C00002065 C00002277 C00002293 | 1 / 1 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000208 C00000209 C00002057 C00002058 C00002277 C00002293 | 0 / 0 |
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00001388 C00002020 C00002057 C00002058 C00002277 C00002293 | 1 / 4 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000208 C00000209 C00002057 C00002277 C00002292 C00002293 | 1 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00000208 C00000209 C00002057 C00002065 C00002277 C00002293 | 0 / 1 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000208 C00000209 C00002057 C00002277 C00002293 | 1 / 1 |
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00002043 C00002053 C00002065 C00002074 C00002292 | 3 / 2 |
| P10828 | Thyroid hormone receptor beta | NR1A2 | C00001345 C00002020 C00002035 C00002056 C00029420 | 3 / 1 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 3 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 1 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 1 / 0 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00000208 C00000209 C00002057 C00002277 C00002293 | 2 / 2 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000208 C00000209 C00002057 C00002277 C00002293 | 1 / 0 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P04066 | Tissue alpha-L-fucosidase | Enzyme | C00002035 C00002038 C00029420 C00049941 C00049947 | 1 / 2 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000208 C00000209 C00002057 C00002277 C00002293 | 5 / 9 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000208 C00000209 C00002057 C00002277 C00002293 | 2 / 0 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| Q14697 | Neutral alpha-glucosidase AB | Enzyme | C00002035 C00002038 C00029420 C00049941 C00049947 | 0 / 0 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 1 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000208 C00000209 C00002057 C00002277 C00002293 | 1 / 1 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| Q9HCG7 | Non-lysosomal glucosylceramidase | Enzyme | C00002035 C00002038 C00029420 C00049941 C00049947 | 1 / 0 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000208 C00000209 C00002057 C00002277 C00002293 | 1 / 8 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 2 / 0 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 1 / 1 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 1 / 0 |
| P08246 | Neutrophil elastase | S1A | C00000208 C00000209 C00002057 C00002277 C00002293 | 2 / 1 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000208 C00000209 C00002057 C00002277 C00002293 | 2 / 1 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002065 C00002074 C00002277 C00002292 C00002293 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00000208 C00000209 C00002057 C00002277 C00002293 | 1 / 1 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 1 / 0 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| Q7Z2H8 | Proton-coupled amino acid transporter 1 | Unclassified protein | C00000210 C00001343 C00001370 C00001387 C00001388 | 0 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00000208 C00000209 C00002057 C00002277 C00002293 | 1 / 0 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 1 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P03956 | Interstitial collagenase | M10A | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 1 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 1 / 0 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000208 C00000209 C00002057 C00002277 C00002293 | 0 / 0 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00000208 C00002066 C00002285 C00002286 C00002298 | 0 / 0 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00000208 C00000209 C00002057 C00002277 C00002293 | 1 / 2 |
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00002057 C00002066 C00007256 C00036384 | 1 / 1 |
| P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00002053 C00002277 C00002292 C00002293 | 0 / 0 |
| O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00002057 C00002277 C00002292 C00002293 | 0 / 0 |
| P35573 | Glycogen debranching enzyme | Enzyme | C00002035 C00029420 C00036384 C00036506 | 1 / 1 |
| O95264 | 5-hydroxytryptamine receptor 3B | NS | C00002057 C00002305 C00025552 | 0 / 0 |
| Q16637 | Survival motor neuron protein | Unclassified protein | C00002015 C00002065 C00002066 | 4 / 1 |
| Q99250 | Sodium channel protein type 2 subunit alpha | SCN alpha, NaV1.x | C00002277 C00002292 C00002293 | 2 / 2 |
| P39748 | Flap endonuclease 1 | Enzyme | C00002015 C00002053 C00002280 | 0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002057 C00002065 C00002066 | 0 / 0 |
| Q9NY46 | Sodium channel protein type 3 subunit alpha | SCN alpha, NaV1.x | C00002277 C00002292 C00002293 | 0 / 0 |
| O43451 | Maltase-glucoamylase, intestinal | Hydrolase | C00002035 C00029420 C00036384 | 0 / 0 |
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00002051 C00002066 C00002292 | 0 / 0 |
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002065 C00002066 C00037055 | 7 / 37 |
| Q99700 | Ataxin-2 | Unclassified protein | C00002053 C00002065 C00002066 | 1 / 1 |
| P54132 | Bloom syndrome protein | Enzyme | C00001343 C00002277 C00002293 | 1 / 2 |
| Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00002057 C00002277 C00002293 | 1 / 1 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002065 C00002066 C00037055 | 3 / 3 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00002020 C00002057 C00007256 | 2 / 0 |
| P06746 | DNA polymerase beta | Enzyme | C00002015 C00002277 C00002293 | 0 / 0 |
| P46098 | 5-hydroxytryptamine receptor 3A | NS | C00002057 C00002305 C00025552 | 0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002015 C00002035 C00029420 | 0 / 0 |
| P02768 | Serum albumin | Secreted protein | C00002277 C00002292 C00002293 | 0 / 0 |
| P35498 | Sodium channel protein type 1 subunit alpha | SCN alpha, NaV1.x | C00002277 C00002292 C00002293 | 3 / 2 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002065 C00002277 C00002293 | 0 / 0 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00001555 C00002066 C00007256 | 1 / 0 |
| Q9Y2E5 | Epididymis-specific alpha-mannosidase | Enzyme | C00002035 C00029420 | 0 / 0 |
| P16278 | Beta-galactosidase | Enzyme | C00002035 C00029420 | 4 / 6 |
| P06280 | Alpha-galactosidase A | Enzyme | C00002035 C00029420 | 1 / 1 |
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002035 C00029420 | 0 / 0 |
| Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00002035 C00029420 | 0 / 0 |
| O00462 | Beta-mannosidase | Enzyme | C00002035 C00029420 | 1 / 2 |
| Q6P4F1 | Alpha-(1,3)-fucosyltransferase 10 | Enzyme | C00002035 C00029420 | 0 / 0 |
| Q9H227 | Cytosolic beta-glucosidase | Enzyme | C00002035 C00029420 | 0 / 0 |
| P08183 | Multidrug resistance protein 1 | drug | C00002065 C00002292 | 1 / 0 |
| O76082 | Solute carrier family 22 member 5 | Unclassified protein | C00000208 C00002057 | 1 / 2 |
| Q9P0Z9 | Peroxisomal sarcosine oxidase | Enzyme | C00000210 C00001387 | 0 / 0 |
| P55055 | Oxysterols receptor LXR-beta | NR1H3 | C00002035 C00029420 | 0 / 0 |
| Q16739 | Ceramide glucosyltransferase | Transferase | C00002035 C00029420 | 0 / 0 |
| O00754 | Lysosomal alpha-mannosidase | Enzyme | C00002035 C00029420 | 1 / 2 |
| O43280 | Trehalase | Enzyme | C00002035 C00029420 | 0 / 0 |
| P11473 | Vitamin D3 receptor | NR1I1 | C00002066 C00007256 | 2 / 3 |
| P23458 | Tyrosine-protein kinase JAK1 | Jakb | C00002035 C00029420 | 0 / 0 |
| O15118 | Niemann-Pick C1 protein | Unclassified protein | C00002065 C00002066 | 1 / 1 |
| O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00000208 C00002057 | 0 / 0 |
| Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00002066 C00037055 | 0 / 0 |
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000208 C00007256 | 0 / 0 |
| P09848 | Lactase-phlorizin hydrolase | Enzyme | C00002035 C00029420 | 1 / 1 |
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00002057 C00002066 | 2 / 0 |
| P51151 | Ras-related protein Rab-9A | Unclassified protein | C00002065 C00002066 | 0 / 0 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00002015 C00002298 | 7 / 3 |
| P14410 | Sucrase-isomaltase, intestinal | Enzyme | C00002035 C00029420 | 1 / 1 |
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00000208 C00007256 | 0 / 0 |
| P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00002065 C00007256 | 2 / 2 |
| P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00002057 | 0 / 0 |
| Q05940 | Synaptic vesicular amine transporter | Amine | C00002053 | 0 / 0 |
| O75030 | Microphthalmia-associated transcription factor | Unclassified protein | C00002066 | 4 / 4 |
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002065 | 2 / 2 |
| O75762 | Transient receptor potential cation channel subfamily A member 1 | Unclassified protein | C00002057 | 1 / 0 |
| P34981 | Thyrotropin-releasing hormone receptor | Neuropeptide receptor | C00007256 | 0 / 0 |
| Q9NTG7 | NAD-dependent protein deacetylase sirtuin-3, mitochondrial | Enzyme | C00000209 | 0 / 0 |
| Q96RI1 | Bile acid receptor | NR1H4 | C00002065 | 0 / 0 |
| Q8NER1 | Transient receptor potential cation channel subfamily V member 1 | TRPV (Vanilloid) | C00002065 | 0 / 0 |
| P00338 | L-lactate dehydrogenase A chain | Enzyme | C00007256 | 1 / 5 |
| P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00002065 | 5 / 3 |
| Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00002057 | 1 / 0 |
| P11308 | Transcriptional regulator ERG | Unclassified protein | C00002300 | 1 / 2 |
| P42226 | Signal transducer and activator of transcription 6 | Unclassified protein | C00037055 | 0 / 0 |
| P49019 | Hydroxycarboxylic acid receptor 3 | Hydroxycarboxylic acid receptor | C00000208 | 0 / 0 |
| Q96EB6 | NAD-dependent protein deacetylase sirtuin-1 | Enzyme | C00000209 | 0 / 0 |
| P09874 | Poly [ADP-ribose] polymerase 1 | Enzyme | C00000209 | 0 / 0 |
| P06737 | Glycogen phosphorylase, liver form | Enzyme | C00036384 | 1 / 1 |
| P10145 | Interleukin-8 | Secreted protein | C00002057 | 0 / 0 |
| Q9BXC0 | Hydroxycarboxylic acid receptor 1 | Hydroxycarboxylic acid receptor | C00000208 | 0 / 0 |
| P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00002065 | 4 / 2 |
| Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00000208 | 0 / 0 |
| Q8IXJ6 | NAD-dependent protein deacetylase sirtuin-2 | Enzyme | C00000209 | 0 / 0 |
| P07327 | Alcohol dehydrogenase 1A | Oxidoreductase | C00007256 | 0 / 0 |
| Q9UKM7 | Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase | Enzyme | C00036384 | 1 / 0 |
| P48065 | Sodium- and chloride-dependent betaine transporter | Betaine and GABA Na-symporter | C00002043 | 0 / 0 |
| O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00002053 | 0 / 0 |
| Q9GZT9 | Egl nine homolog 1 | Enzyme | C00001370 | 1 / 1 |
| P11230 | Acetylcholine receptor subunit beta | CHRN beta | C00002057 | 2 / 1 |
| P02708 | Acetylcholine receptor subunit alpha | CHRN alpha | C00002057 | 3 / 2 |
| P28329 | Choline O-acetyltransferase | Enzyme | C00007256 | 1 / 1 |
| P35869 | Aryl hydrocarbon receptor | Transcription Factor | C00002065 | 0 / 0 |
| P07510 | Acetylcholine receptor subunit gamma | CHRN gamma | C00002057 | 2 / 1 |
| Q07001 | Acetylcholine receptor subunit delta | CHRN delta | C00002057 | 3 / 2 |
| P05362 | Intercellular adhesion molecule 1 | Adhesion | C00034476 | 1 / 2 |
| P30926 | Neuronal acetylcholine receptor subunit beta-4 | CHRN beta | C00002057 | 0 / 0 |
| P32297 | Neuronal acetylcholine receptor subunit alpha-3 | CHRN alpha | C00002057 | 1 / 0 |
| P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00002065 | 0 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00001388 | 0 / 0 |
| P12268 | Inosine-5'-monophosphate dehydrogenase 2 | Oxidoreductase | C00007256 | 0 / 0 |
| O00167 | Eyes absent homolog 2 | Enzyme | C00036930 | 0 / 0 |
| O95544 | NAD kinase | Enzyme | C00007256 | 0 / 0 |
| P37840 | Alpha-synuclein | Unclassified protein | C00007256 | 4 / 2 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002057 | 1 / 1 |
| O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00001555 | 0 / 0 |
| Q9NSD5 | Sodium- and chloride-dependent GABA transporter 2 | GABA | C00002043 | 0 / 0 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00007256 | 0 / 0 |
| P30531 | Sodium- and chloride-dependent GABA transporter 1 | GABA | C00002043 | 0 / 0 |
| Q15822 | Neuronal acetylcholine receptor subunit alpha-2 | CHRN alpha | C00002057 | 1 / 1 |
| Q9H015 | Solute carrier family 22 member 4 | Unclassified protein | C00002057 | 1 / 1 |
| P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00002065 | 0 / 0 |
| Q8WXA8 | 5-hydroxytryptamine receptor 3C | NS | C00002057 | 0 / 0 |
| Q70Z44 | 5-hydroxytryptamine receptor 3D | NS | C00002057 | 0 / 0 |
| Q96FL8 | Multidrug and toxin extrusion protein 1 | Cation antiporter | C00000208 | 0 / 0 |
| A5X5Y0 | 5-hydroxytryptamine receptor 3E | NS | C00002057 | 0 / 0 |
| O15244 | Solute carrier family 22 member 2 | Drug uniporter | C00002057 | 0 / 0 |
| Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00002057 | 1 / 0 |
| Q16706 | Alpha-mannosidase 2 | Enzyme | C00036384 | 0 / 0 |
| Q05901 | Neuronal acetylcholine receptor subunit beta-3 | CHRN beta | C00002057 | 0 / 0 |
| Q9NXA8 | NAD-dependent protein deacylase sirtuin-5, mitochondrial | Enzyme | C00000209 | 0 / 0 |
| P30532 | Neuronal acetylcholine receptor subunit alpha-5 | CHRN alpha | C00002057 | 1 / 0 |
| Q06710 | Paired box protein Pax-8 | Unclassified protein | C00002066 | 1 / 2 |
| P48066 | Sodium- and chloride-dependent GABA transporter 3 | GABA | C00002043 | 0 / 0 |
756 Gene in CTD interactions
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000209
C00002020
C00002057
C00002277
C00007256 |
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000208
C00000209
C00002020
C00002057
C00002285 |
| 3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00000208
C00000209
C00002020
C00002057
C00002285 |
| 1141 | CHRNB2, EFNL3, nAChRB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) |
C00002053
C00002057
C00002277
C00002292
|
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000208
C00002053
C00002057
C00002285
|
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000208
C00000209
C00002057
C00002285
|
| 1137 | CHRNA4, BFNC, EBN, EBN1, NACHR, NACHRA4, NACRA4 | cholinergic receptor, nicotinic, alpha 4 (neuronal) |
C00002053
C00002057
C00002277
C00002292
|
| 581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000209
C00002057
C00002285
C00007256
|
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00000208
C00002053
C00002057
C00002285
|
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000208
C00000209
C00002057
C00002285
|
| 1066 | CES1, ACAT, CE-1, CEH, CES2, HMSE, HMSE1, PCE-1, REH, SES1, TGH, hCE-1 | carboxylesterase 1 (EC:3.1.1.1 3.1.1.56) |
C00002277
C00002280
C00002285
C00002305
|
| 6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00000208
C00000209
C00002285
|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00002020
C00002057
C00002285
|
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00002020
C00002057
C00007256
|
| 1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00002057
C00002277
C00002285
|
| 7430 | EZR, CVIL, CVL, VIL2 | ezrin |
C00002057
C00002277
C00002285
|
| 2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00002057
C00002277
C00002285
|
| 7076 | TIMP1, CLGI, EPA, EPO, HCI, TIMP | TIMP metallopeptidase inhibitor 1 |
C00002019
C00002020
C00002057
|
| 142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00000208
C00002057
C00007256
|
| 1234 | CCR5, CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22 | chemokine (C-C motif) receptor 5 (gene/pseudogene) |
C00002057
C00002285
|
| 1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002020
C00002057
|
| 1050 | CEBPA, C/EBP-alpha, CEBP | CCAAT/enhancer binding protein (C/EBP), alpha |
C00000208
C00007256
|
| 216 | ALDH1A1, ALDC, ALDH-E1, ALDH1, ALDH11, PUMB1, RALDH1 | aldehyde dehydrogenase 1 family, member A1 (EC:1.2.1.36) |
C00002057
C00007256
|
| 6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00002053
C00002057
|
| 1139 | CHRNA7, CHRNA7-2, NACHRA7 | cholinergic receptor, nicotinic, alpha 7 (neuronal) |
C00002053
C00002057
|
| 7450 | VWF, F8VWF, VWD | von Willebrand factor |
C00002057
C00002285
|
| 7329 | UBE2I, C358B7.1, P18, UBC9 | ubiquitin-conjugating enzyme E2I (EC:6.3.2.19) |
C00002057
C00002285
|
| 7277 | TUBA4A, H2-ALPHA, TUBA1 | tubulin, alpha 4a |
C00002057
C00002285
|
| 1131 | CHRM3, EGBRS, HM3 | cholinergic receptor, muscarinic 3 |
C00002020
C00002277
|
| 7037 | TFRC, CD71, T9, TFR, TFR1, TR, TRFR, p90 | transferrin receptor |
C00002057
C00002285
|
| 6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00002057
C00002285
|
| 183 | AGT, ANHU, SERPINA8 | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
C00000208
C00002292
|
| 10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00000208
C00000209
|
| 6622 | SNCA, NACP, PARK1, PARK4, PD1 | synuclein, alpha (non A4 component of amyloid precursor) |
C00002057
C00002285
|
| 949 | SCARB1, CD36L1, CLA-1, CLA1, HDLQTL6, SR-BI, SRB1 | scavenger receptor class B, member 1 |
C00000208
C00002285
|
| 5786 | PTPRA, HEPTP, HLPR, HPTPA, HPTPalpha, LRP, PTPA, PTPRL2, R-PTP-alpha, RPTPA | protein tyrosine phosphatase, receptor type, A (EC:3.1.3.48) |
C00002057
C00002285
|
| 5579 | PRKCB, PKC-beta, PKCB, PRKCB1, PRKCB2 | protein kinase C, beta (EC:2.7.11.13) |
C00002057
C00002285
|
| 4915 | NTRK2, GP145-TrkB, TRKB, trk-B | neurotrophic tyrosine kinase, receptor, type 2 (EC:2.7.10.1) |
C00002057
C00002285
|
| 4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00002057
C00002285
|
| 4801 | NFYB, CBF-A, CBF-B, HAP3, NF-YB | nuclear transcription factor Y, beta |
C00002057
C00002285
|
| 4741 | NEFM, NEF3, NF-M, NFM | neurofilament, medium polypeptide |
C00002057
C00002285
|
| 4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00002057
C00002285
|
| 983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00002020
C00002277
|
| 5563 | PRKAA2, AMPK, AMPK2, AMPKa2, PRKAA | protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) |
C00000208
C00000209
|
| 3912 | LAMB1, CLM, LIS5 | laminin, beta 1 |
C00002057
C00002285
|
| 3726 | JUNB, AP-1 | jun B proto-oncogene |
C00002057
C00002285
|
| 3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00002057
C00002285
|
| 3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00000209
C00002285
|
| 3558 | IL2, IL-2, TCGF, lymphokine | interleukin 2 |
C00002057
C00002285
|
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00000208
C00002057
|
| 3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 |
C00002057
C00002285
|
| 3458 | IFNG, IFG, IFI | interferon, gamma |
C00000208
C00002285
|
| 2688 | GH1, GH, GH-N, GHN, IGHD1B, hGH-N | growth hormone 1 |
C00000208
C00002285
|
| 2354 | FOSB, AP-1, G0S3, GOS3, GOSB | FBJ murine osteosarcoma viral oncogene homolog B |
C00002057
C00002285
|
| 4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00002020
C00002057
|
| 2247 | FGF2, BFGF, FGF-2, FGFB, HBGF-2 | fibroblast growth factor 2 (basic) |
C00002057
C00002285
|
| 355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00002057
C00002285
|
| 1909 | EDNRA, ET-A, ETA, ETA-R, ETAR, ETRA, hET-AR | endothelin receptor type A |
C00002057
C00002285
|
| 1621 | DBH, DBM | dopamine beta-hydroxylase (dopamine beta-monooxygenase) (EC:1.14.17.1) |
C00002057
C00002285
|
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002020
C00002057
|
| 7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00002057
C00002285
|
| 10111 | RAD50, NBSLD, RAD502, hRad50 | RAD50 homolog (S. cerevisiae) |
C00002020
C00002057
|
| 1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00000208
C00002285
|
| 1192 | CLIC1, G6, NCC27 | chloride intracellular channel 1 |
C00002057
C00002285
|
| 6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00002020
C00002057
|
| 1138 | CHRNA5, LNCR2 | cholinergic receptor, nicotinic, alpha 5 (neuronal) |
C00002057
C00002285
|
| 999 | CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO | cadherin 1, type 1, E-cadherin (epithelial) |
C00002057
C00002285
|
| 23411 | SIRT1, SIR2L1 | sirtuin 1 |
C00000209
C00007256
|
| 43 | ACHE, ACEE, ARACHE, N-ACHE, YT | acetylcholinesterase (EC:3.1.1.7) |
C00002277
C00002292
|
| 890 | CCNA2, CCN1, CCNA | cyclin A2 |
C00002057
C00002285
|
| 672 | BRCA1, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PPP1R53, PSCP, RNF53 | breast cancer 1, early onset |
C00002020
C00002057
|
| 842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00002057
C00002285
|
| 898 | CCNE1, CCNE | cyclin E1 |
C00002057
C00002277
|
| 9607 | CARTPT, CART | CART prepropeptide |
C00002057
C00002285
|
| 627 | BDNF, ANON2, BULN2 | brain-derived neurotrophic factor |
C00002057
C00002285
|
| 5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00000208
C00002057
|
| 990 | CDC6, CDC18L, HsCDC18, HsCDC6 | cell division cycle 6 |
C00002057
C00002277
|
| 506 | ATP5B, ATPMB, ATPSB | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide (EC:3.6.3.14) |
C00000208
C00002285
|
| 351 | APP, AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2 | amyloid beta (A4) precursor protein |
C00002057
C00002285
|
| 1636 | ACE, ACE1, CD143, DCP, DCP1, ICH, MVCD3 | angiotensin I converting enzyme (EC:3.4.15.1) |
C00002057
C00002285
|
| 7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00000208
C00002057
|
| 10327 | AKR1A1, ALDR1, ALR, ARM, DD3 | aldo-keto reductase family 1, member A1 (aldehyde reductase) (EC:1.1.1.2) |
C00002020
C00007256
|
| 5747 | PTK2, FADK, FAK, FAK1, FRNK, PPP1R71, p125FAK, pp125FAK | protein tyrosine kinase 2 (EC:2.7.10.2) |
C00002277
C00002285
|
| 5111 | PCNA | proliferating cell nuclear antigen |
C00002057
C00002277
|
| 1856 | DVL2 | dishevelled segment polarity protein 2 |
C00002057
C00002277
|
| 1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00002277
C00002285
|
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00000209
C00002057
|
| 1978 | EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I | eukaryotic translation initiation factor 4E binding protein 1 |
C00000209
C00002057
|
| 6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00000209
C00002057
|
| 3760 | KCNJ3, GIRK1, KGA, KIR3.1 | potassium inwardly-rectifying channel, subfamily J, member 3 |
C00002277
C00002292
|
| 2914 | GRM4, GPRC1D, MGLUR4, mGlu4 | glutamate receptor, metabotropic 4 |
C00002277
C00002292
|
| 5894 | RAF1, CRAF, NS5, Raf-1, c-Raf | v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1) |
C00002057
|
| 3815 | KIT, C-Kit, CD117, PBT, SCFR | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1) |
C00002277
|
| 4057 | LTF, GIG12, HLF2, LF | lactotransferrin |
C00002277
|
| 4173 | MCM4, CDC21, CDC54, NKCD, NKGCD, P1-CDC21, hCdc21 | minichromosome maintenance complex component 4 (EC:3.6.4.12) |
C00002277
|
| 4175 | MCM6, MCG40308, Mis5, P105MCM | minichromosome maintenance complex component 6 (EC:3.6.4.12) |
C00002277
|
| 4855 | NOTCH4, INT3, NOTCH3 | notch 4 |
C00002277
|
| 1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00002277
|
| 1392 | CRH, CRF | corticotropin releasing hormone |
C00002277
|
| 5829 | PXN | paxillin |
C00002277
|
| 5881 | RAC3 | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
C00002277
|
| 387 | RHOA, ARH12, ARHA, RHO12, RHOH12 | ras homolog family member A |
C00002277
|
| 6580 | SLC22A1, HOCT1, OCT1, oct1_cds | solute carrier family 22 (organic cation transporter), member 1 |
C00002277
|
| 6582 | SLC22A2, OCT2 | solute carrier family 22 (organic cation transporter), member 2 |
C00002277
|
| 6581 | SLC22A3, EMT, EMTH, OCT3 | solute carrier family 22 (organic cation transporter), member 3 |
C00002277
|
| 6583 | SLC22A4, OCTN1 | solute carrier family 22 (organic cation/zwitterion transporter), member 4 |
C00002277
|
| 7204 | TRIO, ARHGEF23, tgat | trio Rho guanine nucleotide exchange factor (EC:2.7.11.1) |
C00002277
|
| 1132 | CHRM4, HM4, M4R | cholinergic receptor, muscarinic 4 |
C00002277
|
| 72 | ACTG2, ACT, ACTA3, ACTE, ACTL3, ACTSG | actin, gamma 2, smooth muscle, enteric |
C00002285
|
| 88 | ACTN2, CMD1AA | actinin, alpha 2 |
C00002285
|
| 83543 | AIF1L, C9orf58, IBA2 | allograft inflammatory factor 1-like |
C00002285
|
| 9131 | AIFM1, AIF, CMTX4, COWCK, COXPD6, PDCD8 | apoptosis-inducing factor, mitochondrion-associated, 1 |
C00002285
|
| 203 | AK1 | adenylate kinase 1 (EC:2.7.4.3 2.7.4.6) |
C00002285
|
| 1175 | AP2S1, AP17, AP17-DELTA, CLAPS2, HHC3 | adaptor-related protein complex 2, sigma 1 subunit |
C00002285
|
| 325 | APCS, PTX2, SAP | amyloid P component, serum |
C00002285
|
| 23780 | APOL2, APOL-II, APOL3 | apolipoprotein L, 2 |
C00002285
|
| 1129 | CHRM2, HM2 | cholinergic receptor, muscarinic 2 |
C00002277
|
| 9411 | ARHGAP29, PARG1, RP11-255E17.1 | Rho GTPase activating protein 29 |
C00002285
|
| 498 | ATP5A1, ATP5A, ATP5AL2, ATPM, MC5DN4, MOM2, OMR, ORM, hATP1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle |
C00002285
|
| 1128 | CHRM1, HM1, M1, M1R | cholinergic receptor, muscarinic 1 |
C00002277
|
| 518 | ATP5G3, P3 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9) |
C00002285
|
| 374868 | ATP9B, ATPASEP, ATPIIB, NEO1L, hMMR1 | ATPase, class II, type 9B (EC:3.6.3.1) |
C00002285
|
| 4287 | ATXN3, AT3, ATX3, JOS, MJD, MJD1, SCA3 | ataxin 3 (EC:3.4.19.12) |
C00002285
|
| 991 | CDC20, CDC20A, bA276H19.3, p55CDC | cell division cycle 20 |
C00002277
|
| 590 | BCHE, CHE1, CHE2, E1 | butyrylcholinesterase (EC:3.1.1.8) |
C00002285
|
| 958 | CD40, Bp50, CDW40, TNFRSF5, p50 | CD40 molecule, TNF receptor superfamily member 5 |
C00002277
|
| 801 | CALM1, CALML2, CAMI, CPVT4, DD132, PHKD, caM | calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19) |
C00002285
|
| 805 | CALM2, CAMII, PHKD, PHKD2 | calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19) |
C00002285
|
| 816 | CAMK2B, CAM2, CAMK2, CAMKB | calcium/calmodulin-dependent protein kinase II beta (EC:2.7.11.17) |
C00002285
|
| 814 | CAMK4, CaMK_IV, CaMK-GR, IV, caMK | calcium/calmodulin-dependent protein kinase IV (EC:2.7.11.17) |
C00002285
|
| 832 | CAPZB, CAPB, CAPPB, CAPZ | capping protein (actin filament) muscle Z-line, beta |
C00002285
|
| 9134 | CCNE2, CYCE2 | cyclin E2 |
C00002277
|
| 837 | CASP4, ICE(rel)II, ICEREL-II, ICH-2, Mih1/TX, TX | caspase 4, apoptosis-related cysteine peptidase (EC:3.4.22.57) |
C00002285
|
| 896 | CCND3 | cyclin D3 |
C00002277
|
| 887 | CCKBR, CCK-B, CCK2R, GASR | cholecystokinin B receptor |
C00002285
|
| 8900 | CCNA1 | cyclin A1 |
C00002277
|
| 6348 | CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3 | chemokine (C-C motif) ligand 3 |
C00002285
|
| 9564 | BCAR1, CAS, CAS1, CASS1, CRKAS, P130Cas | breast cancer anti-estrogen resistance 1 |
C00002277
|
| 25 | ABL1, ABL, JTK7, bcr/abl, c-ABL, p150, v-abl | c-abl oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2) |
C00002277
|
| 401145 | CCSER1, FAM190A | coiled-coil serine-rich protein 1 |
C00002285
|
| 51622 | CCZ1, C7orf28A, CCZ1A, H_DJ1163J12.2 | CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae) |
C00002285
|
| 960 | CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MIC4, Pgp1 | CD44 molecule (Indian blood group) |
C00002285
|
| 975 | CD81, CVID6, S5.7, TAPA1, TSPAN28 | CD81 molecule |
C00002285
|
| 100126299 | VTRNA2-1, CBL-3, CBL3, MIR886, MIRN886, VTRNA2, hsa-mir-886, hvg-5, nc886 | vault RNA 2-1 |
C00002020
|
| 1015 | CDH17, CDH16, HPT-1, HPT1 | cadherin 17, LI cadherin (liver-intestine) |
C00002285
|
| 8824 | CES2, CE-2, CES2A1, PCE-2, iCE | carboxylesterase 2 (EC:3.1.1.1 3.1.1.84 3.1.1.56) |
C00002285
|
| 56886 | UGGT1, HUGT1, UGCGL1, UGT1 | UDP-glucose glycoprotein glucosyltransferase 1 |
C00002020
|
| 91612 | CHURC1, C14orf52, chch | churchill domain containing 1 |
C00002285
|
| 1152 | CKB, B-CK, CKBB | creatine kinase, brain (EC:2.7.3.2) |
C00002285
|
| 1158 | CKM, CKMM, M-CK | creatine kinase, muscle (EC:2.7.3.2) |
C00002285
|
| 5010 | CLDN11, OSP, OTM | claudin 11 |
C00002285
|
| 8243 | SMC1A, CDLS2, DXS423E, SB1.8, SMC1, SMC1L1, SMC1alpha, SMCB | structural maintenance of chromosomes 1A |
C00002020
|
| 6249 | CLIP1, CLIP, CLIP-170, CLIP170, CYLN1, RSN | CAP-GLY domain containing linker protein 1 |
C00002285
|
| 1212 | CLTB, LCB | clathrin, light chain B |
C00002285
|
| 22866 | CNKSR2, CNK2, KSR2, MAGUIN | connector enhancer of kinase suppressor of Ras 2 |
C00002285
|
| 1268 | CNR1, CANN6, CB-R, CB1, CB1A, CB1K5, CB1R, CNR | cannabinoid receptor 1 (brain) |
C00002285
|
| 81578 | COL21A1, COLA1L, dJ682J15.1, dJ708F5.1 | collagen, type XXI, alpha 1 |
C00002285
|
| 1345 | COX6C | cytochrome c oxidase subunit VIc (EC:1.9.3.1) |
C00002285
|
| 6283 | S100A12, CAAF1, CAGC, CGRP, ENRAGE, MRP-6, MRP6, p6 | S100 calcium binding protein A12 |
C00002020
|
| 1410 | CRYAB, CMD1II, CRYA2, CTPP2, CTRCT16, HSPB5, MFM2 | crystallin, alpha B |
C00002285
|
| 1415 | CRYBB2, CCA2, CRYB2, CRYB2A, CTRCT3, D22S665 | crystallin, beta B2 |
C00002285
|
| 1466 | CSRP2, CRP2, LMO5, SmLIM | cysteine and glycine-rich protein 2 |
C00002285
|
| 1490 | CTGF, CCN2, HCS24, IGFBP8, NOV2 | connective tissue growth factor |
C00002285
|
| 56998 | CTNNBIP1, ICAT | catenin, beta interacting protein 1 |
C00002285
|
| 1501 | CTNND2, GT24, NPRAP | catenin (cadherin-associated protein), delta 2 |
C00002285
|
| 8450 | CUL4B, MRXHF2, MRXS15, MRXSC, SFM2 | cullin 4B |
C00002285
|
| 3627 | CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1 | chemokine (C-X-C motif) ligand 10 |
C00002285
|
| 5810 | RAD1, HRAD1, REC1 | RAD1 homolog (S. pombe) (EC:3.1.11.2) |
C00002020
|
| 1537 | CYC1, MC3DN6, UQCR4 | cytochrome c-1 |
C00002285
|
| 1558 | CYP2C8, CPC8, CYPIIC8, MP-12/MP-20 | cytochrome P450, family 2, subfamily C, polypeptide 8 (EC:1.14.14.1) |
C00002285
|
| 1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00002285
|
| 13121 |
C00002285
|
||
| 5591 | PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350 | protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) |
C00002020
|
| 51428 | DDX41, ABS | DEAD (Asp-Glu-Ala-Asp) box polypeptide 41 (EC:3.6.4.13) |
C00002285
|
| 10522 | DEAF1, NUDR, SPN, ZMYND5 | DEAF1 transcription factor |
C00002285
|
| 1769 | DNAH8, ATPase, hdhc9 | dynein, axonemal, heavy chain 8 |
C00002285
|
| 574351 |
C00002285
|
||
| 10591 | DNPH1, C6orf108, RCL, RP3-330M21.3, dJ330M21.3 | 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
C00002285
|
| 5977 | DPF2, REQ, UBID4, ubi-d4 | D4, zinc and double PHD fingers family 2 |
C00002285
|
| 1812 | DRD1, DADR, DRD1A | dopamine receptor D1 |
C00002285
|
| 1813 | DRD2, D2DR, D2R | dopamine receptor D2 |
C00002285
|
| 1814 | DRD3, D3DR, ETM1, FET1 | dopamine receptor D3 |
C00002285
|
| 1815 | DRD4, D4DR | dopamine receptor D4 |
C00002285
|
| 1821 | DRP2 | dystrophin related protein 2 |
C00002285
|
| 1832 | DSP, DP, DPI, DPII | desmoplakin |
C00002285
|
| 9027 | NAT8, ATase2, CML1, GLA, Hcml1, TSC501, TSC510 | N-acetyltransferase 8 (GCN5-related, putative) |
C00002020
|
| 1937 | EEF1G, EF1G, GIG35 | eukaryotic translation elongation factor 1 gamma |
C00002285
|
| 1984 | EIF5A, EIF-5A, EIF5A1, eIF5AI | eukaryotic translation initiation factor 5A |
C00002285
|
| 1991 | ELANE, ELA2, GE, HLE, HNE, NE, PMN-E, SCN1 | elastase, neutrophil expressed (EC:3.4.21.37) |
C00002285
|
| 375704 | ENHO, C9orf165, UNQ470 | energy homeostasis associated |
C00002285
|
| 2026 | ENO2, NSE | enolase 2 (gamma, neuronal) (EC:4.2.1.11) |
C00002285
|
| 59084 | ENPP5 | ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) |
C00002285
|
| 2050 | EPHB4, HTK, MYK1, TYRO11 | EPH receptor B4 (EC:2.7.10.1) |
C00002285
|
| 2138 | EYA1, BOP, BOR, BOS1 | eyes absent homolog 1 (Drosophila) (EC:3.1.3.16 3.1.3.48) |
C00002285
|
| 51011 | FAHD2A | fumarylacetoacetate hydrolase domain containing 2A (EC:3.-.-.-) |
C00002285
|
| 285596 | FAM153A, NY-REN-7 | family with sequence similarity 153, member A |
C00002285
|
| 4489 | MT1A, MT1, MT1S, MTC | metallothionein 1A |
C00002020
|
| 2222 | FDFT1, DGPT, ERG9, SQS, SS | farnesyl-diphosphate farnesyltransferase 1 (EC:2.5.1.21) |
C00002285
|
| 4436 | MSH2, COCA1, FCC1, HNPCC, HNPCC1, LCFS2 | mutS homolog 2 |
C00002020
|
| 14194 |
C00002285
|
||
| 23767 | FLRT3, HH21 | fibronectin leucine rich transmembrane protein 3 |
C00002285
|
| 4292 | MLH1, COCA2, FCC2, HNPCC, HNPCC2, hMLH1 | mutL homolog 1 |
C00002020
|
| 8061 | FOSL1, FRA, FRA1, fra-1 | FOS-like antigen 1 |
C00002285
|
| 2355 | FOSL2, FRA2 | FOS-like antigen 2 |
C00002285
|
| 2571 | GAD1, CPSQ1, GAD, SCP | glutamate decarboxylase 1 (brain, 67kDa) (EC:4.1.1.15) |
C00002285
|
| 2596 | GAP43, B-50, PP46 | growth associated protein 43 |
C00002285
|
| 79571 | GCC1, GCC1P, GCC88 | GRIP and coiled-coil domain containing 1 |
C00002285
|
| 2669 | GEM, KIR | GTP binding protein overexpressed in skeletal muscle |
C00002285
|
| 2670 | GFAP | glial fibrillary acidic protein |
C00002285
|
| 693215 | MIR630, MIRN630, hsa-mir-630 | microRNA 630 |
C00002020
|
| 2706 | GJB2, CX26, DFNA3, DFNA3A, DFNB1, DFNB1A, HID, KID, NSRD1, PPK | gap junction protein, beta 2, 26kDa |
C00002285
|
| 2775 | GNAO1, EIEE17, G-ALPHA-o, GNAO | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
C00002285
|
| 2782 | GNB1 | guanine nucleotide binding protein (G protein), beta polypeptide 1 |
C00002285
|
| 2823 | GPM6A, GPM6, M6A | glycoprotein M6A |
C00002285
|
| 2824 | GPM6B, M6B | glycoprotein M6B |
C00002285
|
| 2891 | GRIA2, GLUR2, GLURB, GluA2, GluR-K2, HBGR2 | glutamate receptor, ionotropic, AMPA 2 |
C00002285
|
| 2892 | GRIA3, GLUR-C, GLUR-K3, GLUR3, GLURC, GluA3, MRX94 | glutamate receptor, ionotropic, AMPA 3 |
C00002285
|
| 2902 | GRIN1, GluN1, MRD8, NMDA1, NMDAR1, NR1 | glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
C00002285
|
| 2934 | GSN, ADF, AGEL | gelsolin |
C00002285
|
| 9446 | GSTO1, GSTO_1-1, GSTTLp28, P28, SPG-R | glutathione S-transferase omega 1 (EC:2.5.1.18 1.8.5.1 1.20.4.2) |
C00002285
|
| 2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00002285
|
| 610 | HCN2, BCNG-2, BCNG2, HAC-1 | hyperpolarization activated cyclic nucleotide-gated potassium channel 2 |
C00002285
|
| 3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00002285
|
| 9456 | HOMER1, HOMER, HOMER1A, HOMER1B, HOMER1C, SYN47, Ves-1 | homer homolog 1 (Drosophila) |
C00002285
|
| 3241 | HPCAL1, BDR1, HLP2, VILIP-3 | hippocalcin-like 1 |
C00002285
|
| 3309 | HSPA5, BIP, GRP78, MIF2 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
C00002285
|
| 3329 | HSPD1, CPN60, GROEL, HLD4, HSP-60, HSP60, HSP65, HuCHA60, SPG13 | heat shock 60kDa protein 1 (chaperonin) |
C00002285
|
| 407029 | MIR30A, MIRN30A | microRNA 30a |
C00002020
|
| 407026 | MIR29C, MIRN29C, miRNA29C | microRNA 29c |
C00002020
|
| 407017 | MIR26B, MIRN26B, hsa-mir-26b, miR-26b | microRNA 26b |
C00002020
|
| 407015 | MIR26A1, MIR26A, MIRN26A1 | microRNA 26a-1 |
C00002020
|
| 3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00002285
|
| 3623 | INHA | inhibin, alpha |
C00002285
|
| 407010 | MIR23A, MIRN23A, hsa-mir-23a, miRNA23A | microRNA 23a |
C00002020
|
| 10379 | IRF9, IRF-9, ISGF3, ISGF3G, p48 | interferon regulatory factor 9 |
C00002285
|
| 9270 | ITGB1BP1, ICAP-1A, ICAP-1B, ICAP-1alpha, ICAP1, ICAP1A, ICAP1B | integrin beta 1 binding protein 1 |
C00002285
|
| 3694 | ITGB6 | integrin, beta 6 |
C00002285
|
| 406978 | MIR199B, MIRN199B, mir-199b | microRNA 199b |
C00002020
|
| 100302129 | MIR1915, MIRN1915, hsa-mir-1915 | microRNA 1915 |
C00002020
|
| 3727 | JUND, AP-1 | jun D proto-oncogene |
C00002285
|
| 3763 | KCNJ6, BIR1, GIRK-2, GIRK2, KATP-2, KATP2, KCNJ7, KIR3.2, hiGIRK2 | potassium inwardly-rectifying channel, subfamily J, member 6 |
C00002285
|
| 9365 | KL | klotho (EC:3.2.1.31) |
C00002285
|
| 51088 | KLHL5 | kelch-like family member 5 |
C00002285
|
| 889 | KRIT1, CAM, CCM1 | KRIT1, ankyrin repeat containing |
C00002285
|
| 100302137 | MIR1914, MIRN1914, hsa-mir-1914 | microRNA 1914 |
C00002020
|
| 470879 |
C00002285
|
||
| 9079 | LDB2, CLIM1, LDB1 | LIM domain binding 2 |
C00002285
|
| 55327 | LIN7C, LIN-7-C, LIN-7C, MALS-3, MALS3, VELI3 | lin-7 homolog C (C. elegans) |
C00002285
|
| 1902 | LPAR1, EDG2, GPR26, Gpcr26, LPA1, Mrec1.3, VZG1, edg-2, rec.1.3, vzg-1 | lysophosphatidic acid receptor 1 |
C00002285
|
| 57554 | LRRC7, DENSIN | leucine rich repeat containing 7 |
C00002285
|
| 114569 | MAL2 | mal, T-cell differentiation protein 2 (gene/pseudogene) |
C00002285
|
| 37838 |
C00002285
|
||
| 79694 | MANEA, ENDO, hEndo | mannosidase, endo-alpha (EC:3.2.1.130) |
C00002285
|
| 4131 | MAP1B, FUTSCH, MAP5 | microtubule-associated protein 1B |
C00002285
|
| 5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00002285
|
| 406937 | MIR145, MIRN145, miR-145, miRNA145 | microRNA 145 |
C00002020
|
| 5602 | MAPK10, JNK3, JNK3A, PRKM10, SAPK1b, p493F12, p54bSAPK | mitogen-activated protein kinase 10 (EC:2.7.11.24) |
C00002285
|
| 406935 | MIR143, MIRN143 | microRNA 143 |
C00002020
|
| 64844 | MARCH7, AXO, AXOT, MARCH-VII, RNF177 | membrane-associated ring finger (C3HC4) 7, E3 ubiquitin protein ligase |
C00002285
|
| 4155 | MBP | myelin basic protein |
C00002285
|
| 4190 | MDH1, MDH-s, MDHA, MGC:1375, MOR2 | malate dehydrogenase 1, NAD (soluble) (EC:1.1.1.37 1.1.1.96) |
C00002285
|
| 4204 | MECP2, AUTSX3, MRX16, MRX79, MRXS13, MRXSL, PPMX, RS, RTS, RTT | methyl CpG binding protein 2 (Rett syndrome) |
C00002285
|
| 4209 | MEF2D | myocyte enhancer factor 2D |
C00002285
|
| 406921 | MIR132, MIRN132, miRNA132 | microRNA 132 |
C00002285
|
| 406994 | MIR212, MIRN212, mir-212 | microRNA 212 |
C00002285
|
| 406927 | MIR136, MIRN136, miRNA136 | microRNA 136 |
C00002020
|
| 39610 |
C00002285
|
||
| 79664 | NARG2, BRCC1 | NMDA receptor regulated 2 |
C00002285
|
| 57447 | NDRG2, SYLD | NDRG family member 2 |
C00002285
|
| 4705 | NDUFA10, CI-42KD, CI-42k | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa (EC:1.6.5.3 1.6.99.3) |
C00002285
|
| 4720 | NDUFS2, CI-49 | NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3) |
C00002285
|
| 23327 | NEDD4L, NEDD4-2, NEDD4.2, RSP5, hNEDD4-2 | neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase (EC:6.3.2.-) |
C00002285
|
| 4747 | NEFL, CMT1F, CMT2E, NF-L, NF68, NFL | neurofilament, light polypeptide |
C00002285
|
| 100302270 | MIR1305, MIRN1305, hsa-mir-1305 | microRNA 1305 |
C00002020
|
| 81831 | NETO2, BTCL2, NEOT2 | neuropilin (NRP) and tolloid (TLL)-like 2 |
C00002285
|
| 4779 | NFE2L1, LCR-F1, NRF1, TCF11 | nuclear factor, erythroid 2-like 1 |
C00002285
|
| 100302276 | MIR1290, MIRN1290, hsa-mir-1290 | microRNA 1290 |
C00002020
|
| 4803 | NGF, Beta-NGF, HSAN5, NGFB | nerve growth factor (beta polypeptide) |
C00002285
|
| 4831 | NME2, NDKB, NDPK-B, NDPKB, NM23-H2, NM23B, PUF | NME/NM23 nucleoside diphosphate kinase 2 (EC:2.7.4.6 2.7.13.3) |
C00002285
|
| 100302233 | MIR1268A, MIR1268, MIRN1268, hsa-mir-1268, hsa-mir-1268a | microRNA 1268a |
C00002020
|
| 23117 | NPIPB3, KIAA0220L, NPIPB5, NPIPL3 | nuclear pore complex interacting protein family, member B3 |
C00002285
|
| 4878 | NPPA, ANF, ANP, ATFB6, CDD-ANF, PND | natriuretic peptide A |
C00002285
|
| 9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00002285
|
| 2908 | NR3C1, GCCR, GCR, GR, GRL | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
C00002285
|
| 4929 | NR4A2, HZF-3, NOT, NURR1, RNR1, TINUR | nuclear receptor subfamily 4, group A, member 2 |
C00002285
|
| 4905 | NSF, SKD2 | N-ethylmaleimide-sensitive factor (EC:3.6.4.6) |
C00002285
|
| 100302142 | MIR1246, MIRN1246, hsa-mir-1246 | microRNA 1246 |
C00002020
|
| 64710 | NUCKS1, NUCKS | nuclear casein kinase and cyclin-dependent kinase substrate 1 |
C00002285
|
| 4983 | OPHN1, ARHGAP41, MRX60, OPN1 | oligophrenin 1 |
C00002285
|
| 4988 | OPRM1, LMOR, M-OR-1, MOP, MOR, MOR1, OPRM | opioid receptor, mu 1 |
C00002285
|
| 114876 | OSBPL1A, ORP-1, ORP1, OSBPL1B | oxysterol binding protein-like 1A |
C00002285
|
| 56924 | PAK6, PAK5 | p21 protein (Cdc42/Rac)-activated kinase 6 (EC:2.7.11.1) |
C00002285
|
| 7849 | PAX8 | paired box 8 |
C00002285
|
| 5100 | PCDH8, ARCADLIN, PAPC | protocadherin 8 |
C00002285
|
| 56146 | PCDHA2, PCDH-ALPHA2 | protocadherin alpha 2 |
C00002285
|
| 56114 | PCDHGA1, PCDH-GAMMA-A1 | protocadherin gamma subfamily A, 1 |
C00002285
|
| 27344 | PCSK1N, PROSAAS, SAAS | proprotein convertase subtilisin/kexin type 1 inhibitor |
C00002285
|
| 5126 | PCSK2, NEC_2, NEC-2, NEC2, PC2, SPC2 | proprotein convertase subtilisin/kexin type 2 (EC:3.4.21.94) |
C00002285
|
| 10081 | PDCD7, ES18, HES18 | programmed cell death 7 |
C00002285
|
| 9659 | PDE4DIP, CMYA2, MMGL | phosphodiesterase 4D interacting protein |
C00002285
|
| 5173 | PDYN, ADCA, PENKB, SCA23 | prodynorphin |
C00002285
|
| 5037 | PEBP1, HCNP, HCNPpp, PBP, PEBP, PEBP-1, RKIP | phosphatidylethanolamine binding protein 1 |
C00002285
|
| 5179 | PENK | proenkephalin |
C00002285
|
| 5196 | PF4, CXCL4, PF-4, SCYB4 | platelet factor 4 |
C00002285
|
| 5216 | PFN1, ALS18 | profilin 1 |
C00002285
|
| 5292 | PIM1, PIM | pim-1 oncogene (EC:2.7.11.1) |
C00002285
|
| 5309 | PITX3, ASMD, CTPP4, CTRCT11, PTX3 | paired-like homeodomain 3 |
C00002285
|
| 5354 | PLP1, GPM6C, HLD1, MMPL, PLP, PLP/DM20, PMD, SPG2 | proteolipid protein 1 |
C00002285
|
| 56937 | PMEPA1, STAG1, TMEPAI | prostate transmembrane protein, androgen induced 1 |
C00002285
|
| 5443 | POMC, ACTH, CLIP, LPH, MSH, NPP, POC | proopiomelanocortin |
C00002285
|
| 8612 | PPAP2C, LPP2, PAP-2c, PAP2-g | phosphatidic acid phosphatase type 2C (EC:3.1.3.4) |
C00002285
|
| 5473 | PPBP, B-TG1, Beta-TG, CTAP-III, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, PBP, SCYB7, TC1, TC2, TGB, TGB1, THBGB, THBGB1 | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
C00002285
|
| 8541 | PPFIA3, LPNA3 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
C00002285
|
| 8496 | PPFIBP1, L2, SGT2, hSGT2, hSgt2p | PTPRF interacting protein, binding protein 1 (liprin beta 1) |
C00002285
|
| 5481 | PPID, CYP-40, CYPD | peptidylprolyl isomerase D (EC:5.2.1.8) |
C00002285
|
| 5499 | PPP1CA, PP-1A, PP1A, PP1alpha, PPP1A | protein phosphatase 1, catalytic subunit, alpha isozyme (EC:3.1.3.16) |
C00002285
|
| 5515 | PPP2CA, PP2Ac, PP2CA, PP2Calpha, RP-C | protein phosphatase 2, catalytic subunit, alpha isozyme (EC:3.1.3.16) |
C00002285
|
| 5516 | PPP2CB, PP2Abeta, PP2CB | protein phosphatase 2, catalytic subunit, beta isozyme (EC:3.1.3.16) |
C00002285
|
| 5522 | PPP2R2C, B55-GAMMA, IMYPNO, IMYPNO1, PR52, PR55G | protein phosphatase 2, regulatory subunit B, gamma (EC:3.1.3.16) |
C00002285
|
| 7001 | PRDX2, NKEF-B, NKEFB, PRP, PRX2, PRXII, PTX1, TDPX1, TPX1, TSA | peroxiredoxin 2 (EC:1.11.1.15) |
C00002285
|
| 25824 | PRDX5, ACR1, AOEB166, B166, PLP, PMP20, PRDX6, PRXV, prx-V | peroxiredoxin 5 (EC:1.11.1.15) |
C00002285
|
| 9581 | PREPL | prolyl endopeptidase-like (EC:3.4.21.-) |
C00002285
|
| 100188847 | MIR1225, MIRN1225 | microRNA 1225 |
C00002020
|
| 5617 | PRL | prolactin |
C00002285
|
| 5657 | PRTN3, ACPA, AGP7, C-ANCA, CANCA, MBN, MBT, NP-4, NP4, P29, PR-3, PR3 | proteinase 3 (EC:3.4.21.76) |
C00002285
|
| 23198 | PSME4, PA200 | proteasome (prosome, macropain) activator subunit 4 |
C00002285
|
| 5764 | PTN, HARP, HBGF8, HBNF, NEGF1 | pleiotrophin |
C00002285
|
| 100302175 | MIR1207, MIRN1207, hsa-mir-1207 | microRNA 1207 |
C00002020
|
| 5787 | PTPRB, HPTP-BETA, HPTPB, PTPB, R-PTP-BETA, VEPTP | protein tyrosine phosphatase, receptor type, B (EC:3.1.3.48) |
C00002285
|
| 5816 | PVALB, D22S749 | parvalbumin |
C00002285
|
| 8434 | RECK, ST15 | reversion-inducing-cysteine-rich protein with kazal motifs |
C00002285
|
| 6204 | RPS10, DBA9, S10 | ribosomal protein S10 |
C00002285
|
| 6203 | RPS9, S9 | ribosomal protein S9 |
C00002285
|
| 23429 | RYBP, AAP1, DEDAF, YEAF1 | RING1 and YY1 binding protein |
C00002285
|
| 4128 | MAOA, MAO-A | monoamine oxidase A (EC:1.4.3.4) |
C00002020
|
| 6403 | SELP, CD62, CD62P, GMP140, GRMP, LECAM3, PADGEM, PSEL | selectin P (granule membrane protein 140kDa, antigen CD62) |
C00002285
|
| 7869 | SEMA3B, LUCA-1, SEMA5, SEMAA, SemA, semaV | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
C00002285
|
| 57556 | SEMA6A, HT018, SEMA, SEMA6A1, SEMAQ, VIA | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
C00002285
|
| 5414 | SEPT4, ARTS, BRADEION, CE5B3, H5, MART, PNUTL2, SEP4, hCDCREL-2 | septin 4 |
C00002285
|
| 6443 | SGCB, A3b, LGMD2E, SGC | sarcoglycan, beta (43kDa dystrophin-associated glycoprotein) |
C00002285
|
| 23678 | SGK3, CISK, SGK2, SGKL | serum/glucocorticoid regulated kinase family, member 3 (EC:2.7.11.1) |
C00002285
|
| 22941 | SHANK2, AUTS17, CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3 | SH3 and multiple ankyrin repeat domains 2 |
C00002285
|
| 10280 | SIGMAR1, ALS16, OPRS1, SIG-1R, SR-BP, SR-BP1, SRBP, hSigmaR1, sigma1R | sigma non-opioid intracellular receptor 1 |
C00002285
|
| 6554 | SLC10A1, NTCP | solute carrier family 10 (sodium/bile acid cotransporter), member 1 |
C00002285
|
| 6571 | SLC18A2, SVAT, SVMT, VAT2, VMAT2 | solute carrier family 18 (vesicular monoamine transporter), member 2 |
C00002285
|
| 9389 | SLC22A14, OCTL2, OCTL4, ORCTL4 | solute carrier family 22, member 14 |
C00002285
|
| 79085 | SLC25A23, APC2, MCSC2, SCaMC-3 | solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 |
C00002285
|
| 51312 | SLC25A37, MFRN, MFRN1, MSC, MSCP, PRO1278, PRO1584, PRO2217 | solute carrier family 25 (mitochondrial iron transporter), member 37 |
C00002285
|
| 23443 | SLC35A3 | solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3 |
C00002285
|
| 6530 | SLC6A2, NAT1, NET, NET1, SLC6A5 | solute carrier family 6 (neurotransmitter transporter), member 2 |
C00002285
|
| 6531 | SLC6A3, DAT, DAT1, PKDYS | solute carrier family 6 (neurotransmitter transporter), member 3 |
C00002285
|
| 6532 | SLC6A4, 5-HTT, 5-HTTLPR, 5HTT, HTT, OCD1, SERT, SERT1, hSERT | solute carrier family 6 (neurotransmitter transporter), member 4 |
C00002285
|
| 6549 | SLC9A2, NHE2 | solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 |
C00002285
|
| 51451 | LCMT1, LCMT, PPMT1 | leucine carboxyl methyltransferase 1 (EC:2.1.1.233) |
C00002020
|
| 51182 | HSPA14, HSP70-4, HSP70L1 | heat shock 70kDa protein 14 |
C00002020
|
| 6687 | SPG7, CAR, CMAR, PGN, SPG5C | spastic paraplegia 7 (pure and complicated autosomal recessive) |
C00002285
|
| 6711 | SPTBN1, ELF, SPTB2, betaSpII | spectrin, beta, non-erythrocytic 1 |
C00002285
|
| 6748 | SSR4, TRAPD | signal sequence receptor, delta |
C00002285
|
| 10402 | ST3GAL6, SIAT10, ST3GALVI | ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (EC:2.4.99.-) |
C00002285
|
| 23208 | SYT11, SYT12, sytXI | synaptotagmin XI |
C00002285
|
| 57586 | SYT13 | synaptotagmin XIII |
C00002285
|
| 6870 | TACR3, HH11, NK-3R, NK3R, NKR, TAC3RL | tachykinin receptor 3 |
C00002285
|
| 29114 | TAGLN3, NP22, NP24, NP25 | transgelin 3 |
C00002285
|
| 55714 | TENM3, MCOPCB9, ODZ3, TNM3, Ten-m3 | teneurin transmembrane protein 3 |
C00002285
|
| 7018 | TF, PRO1557, PRO2086, TFQTL1 | transferrin |
C00002285
|
| 7023 | TFAP4, AP-4, bHLHc41 | transcription factor AP-4 (activating enhancer binding protein 4) |
C00002285
|
| 404672 | GTF2H5, C6orf175, TFB5, TFIIH, TGF2H5, TTD, TTD-A, TTDA, bA120J8.2 | general transcription factor IIH, polypeptide 5 |
C00002020
|
| 261726 | TIPRL, TIP, TIP41, dJ69E11.3 | TIP41, TOR signaling pathway regulator-like (S. cerevisiae) |
C00002285
|
| 7086 | TKT, TK, TKT1 | transketolase (EC:2.2.1.1) |
C00002285
|
| 2966 | GTF2H2, BTF2, BTF2P44, T-BTF2P44, TFIIH, p44 | general transcription factor IIH, polypeptide 2, 44kDa |
C00002020
|
| 8764 | TNFRSF14, ATAR, CD270, HVEA, HVEM, LIGHTR, TR2 | tumor necrosis factor receptor superfamily, member 14 |
C00002285
|
| 7137 | TNNI3, CMD1FF, CMD2A, CMH7, RCM1, TNNC1, cTnI | troponin I type 3 (cardiac) |
C00002285
|
| 10140 | TOB1, APRO6, PIG49, TOB, TROB, TROB1 | transducer of ERBB2, 1 |
C00002285
|
| 58476 | TP53INP2, C20orf110, DOR, PINH, dJ1181N3.1 | tumor protein p53 inducible nuclear protein 2 |
C00002285
|
| 406303 |
C00002285
|
||
| 113457 | TUBA3D, H2-ALPHA | tubulin, alpha 3d |
C00002285
|
| 2937 | GSS, GSHS | glutathione synthetase (EC:6.3.2.3) |
C00002020
|
| 51807 | TUBA8, TUBAL2 | tubulin, alpha 8 |
C00002285
|
| 7297 | TYK2, JTK1 | tyrosine kinase 2 (EC:2.7.10.2) |
C00002285
|
| 9518 | GDF15, GDF-15, MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB | growth differentiation factor 15 |
C00002020
|
| 9040 | UBE2M, UBC-RS2, UBC12, hUbc12 | ubiquitin-conjugating enzyme E2M (EC:6.3.2.19) |
C00002285
|
| 7345 | UCHL1, NDGOA, PARK5, PGP_9.5, PGP9.5, PGP95, Uch-L1 | ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) (EC:3.4.19.12) |
C00002285
|
| 7357 | UGCG, GCS, GLCT1 | UDP-glucose ceramide glucosyltransferase (EC:2.4.1.80) |
C00002285
|
| 2189 | FANCG, FAG, XRCC9 | Fanconi anemia, complementation group G |
C00002020
|
| 7531 | YWHAE, 14-3-3E, KCIP-1, MDCR, MDS | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide |
C00002285
|
| 7533 | YWHAH, YWHA1 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide |
C00002285
|
| 2068 | ERCC2, COFS2, EM9, TTD, XPD | excision repair cross-complementing rodent repair deficiency, complementation group 2 (EC:3.6.4.12) |
C00002020
|
| 9521 | EEF1E1, AIMP3, P18 | eukaryotic translation elongation factor 1 epsilon 1 |
C00002020
|
| 3301 | DNAJA1, DJ-2, DjA1, HDJ2, HSDJ, HSJ2, HSPF4, NEDD7, hDJ-2 | DnaJ (Hsp40) homolog, subfamily A, member 1 |
C00002020
|
| 219 | ALDH1B1, ALDH5, ALDHX | aldehyde dehydrogenase 1 family, member B1 (EC:1.2.1.3) |
C00007256
|
| 217 | ALDH2, ALDH-E2, ALDHI, ALDM | aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3) |
C00007256
|
| 218 | ALDH3A1, ALDH3, ALDHIII | aldehyde dehydrogenase 3 family, member A1 (EC:1.2.1.5) |
C00007256
|
| 847 | CAT | catalase (EC:1.11.1.6) |
C00007256
|
| 54541 | DDIT4, Dig2, REDD-1, REDD1 | DNA-damage-inducible transcript 4 |
C00002020
|
| 1727 | CYB5R3, B5R, DIA1 | cytochrome b5 reductase 3 (EC:1.6.2.2) |
C00007256
|
| 10495 | ENOX2, APK1, COVA1, tNOX | ecto-NOX disulfide-thiol exchanger 2 |
C00007256
|
| 2597 | GAPDH, G3PD, GAPD | glyceraldehyde-3-phosphate dehydrogenase (EC:1.2.1.12) |
C00007256
|
| 3033 | HADH, HAD, HADH1, HADHSC, HCDH, HHF4, MSCHAD, SCHAD | hydroxyacyl-CoA dehydrogenase (EC:1.1.1.35) |
C00007256
|
| 15461 |
C00007256
|
||
| 55191 | NADSYN1 | NAD synthetase 1 (EC:6.3.5.1) |
C00007256
|
| 1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00007256
|
| 64858 | DCLRE1B, APOLLO, SNM1B, SNMIB | DNA cross-link repair 1B |
C00002020
|
| 195814 | SDR16C5, RDH#2, RDH-E2, RDHE2 | short chain dehydrogenase/reductase family 16C, member 5 (EC:1.1.1.105) |
C00007256
|
| 56603 | CYP26B1, CYP26A2, P450RAI-2, P450RAI2, RHFCA | cytochrome P450, family 26, subfamily B, polypeptide 1 |
C00002020
|
| 6610 | SMPD2, ISC1, NSMASE, NSMASE1 | sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase) (EC:3.1.4.12) |
C00007256
|
| 8877 | SPHK1, SPHK | sphingosine kinase 1 (EC:2.7.1.91) |
C00007256
|
| 7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00007256
|
| 19 | ABCA1, ABC-1, ABC1, CERP, HDLDT1, TGD | ATP-binding cassette, sub-family A (ABC1), member 1 |
C00000208
|
| 9370 | ADIPOQ, ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1, GBP28 | adiponectin, C1Q and collagen domain containing |
C00000208
|
| 8208 | CHAF1B, CAF-1, CAF-IP60, CAF1, CAF1A, CAF1P60, MPHOSPH7, MPP7 | chromatin assembly factor 1, subunit B (p60) |
C00002020
|
| 197 | AHSG, A2HS, AHS, FETUA, HSGA | alpha-2-HS-glycoprotein |
C00000208
|
| 335 | APOA1 | apolipoprotein A-I |
C00000208
|
| 338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00000208
|
| 1052 | CEBPD, C/EBP-delta, CELF, CRP3, NF-IL6-beta | CCAAT/enhancer binding protein (C/EBP), delta |
C00000208
|
| 1376 | CPT2, CPT1, CPTASE, IIAE4 | carnitine palmitoyltransferase 2 (EC:2.3.1.21) |
C00000208
|
| 84649 | DGAT2, ARAT, GS1999FULL | diacylglycerol O-acyltransferase 2 (EC:2.3.1.20 2.3.1.76) |
C00000208
|
| 2149 | F2R, CF2R, HTR, PAR-1, PAR1, TR | coagulation factor II (thrombin) receptor |
C00000208
|
| 2194 | FASN, FAS, OA-519, SDR27X1 | fatty acid synthase (EC:2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 3.1.2.14 4.2.1.59 1.1.1.100 1.3.1.39) |
C00000208
|
| 2641 | GCG, GLP1, GLP2, GRPP | glucagon |
C00000208
|
| 338442 | HCAR2, GPR109A, HCA2, HM74a, HM74b, NIACR1, PUMAG, Puma-g | hydroxycarboxylic acid receptor 2 |
C00000208
|
| 8843 | HCAR3, GPR109B, HCA3, HM74, PUMAG, Puma-g | hydroxycarboxylic acid receptor 3 |
C00000208
|
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00000208
|
| 3952 | LEP, LEPD, OB, OBS | leptin |
C00000208
|
| 3991 | LIPE, HSL, LHS | lipase, hormone-sensitive (EC:3.1.1.79) |
C00000208
|
| 4018 | LPA, AK38, APOA, LP | lipoprotein, Lp(a) (EC:3.4.21.-) |
C00000208
|
| 10062 | NR1H3, LXR-a, LXRA, RLD-1 | nuclear receptor subfamily 1, group H, member 3 |
C00000208
|
| 5175 | PECAM1, CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM | platelet/endothelial cell adhesion molecule 1 |
C00000208
|
| 7941 | PLA2G7, LDL-PLA2, LP-PLA2, PAFAD, PAFAH | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (EC:3.1.1.47) |
C00000208
|
| 5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00000208
|
| 5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00000208
|
| 10036 | CHAF1A, CAF-1, CAF1, CAF1B, CAF1P150, P150 | chromatin assembly factor 1, subunit A (p150) |
C00002020
|
| 995 | CDC25C, CDC25, PPP1R60 | cell division cycle 25C (EC:3.1.3.48) |
C00002020
|
| 5729 | PTGDR, AS1, ASRT1, DP, DP1, PTGDR1 | prostaglandin D2 receptor (DP) |
C00000208
|
| 5730 | PTGDS, L-PGDS, LPGDS, PDS, PGD2, PGDS, PGDS2 | prostaglandin D2 synthase 21kDa (brain) (EC:5.3.99.2) |
C00000208
|
| 5742 | PTGS1, COX1, COX3, PCOX1, PES-1, PGG/HS, PGHS-1, PGHS1, PHS1, PTGHS | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00000208
|
| 902 | CCNH, CAK, p34, p37 | cyclin H |
C00002020
|
| 56729 | RETN, ADSF, FIZZ3, RETN1, RSTN, XCP1 | resistin |
C00000208
|
| 328 | APEX1, APE, APE1, APEN, APEX, APX, HAP1, REF1 | APEX nuclease (multifunctional DNA repair enzyme) 1 (EC:4.2.99.18) |
C00002020
|
| 7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00000208
|
| 223 | ALDH9A1, ALDH4, ALDH7, ALDH9, E3, TMABADH | aldehyde dehydrogenase 9 family, member A1 (EC:1.2.1.3 1.2.1.19 1.2.1.47) |
C00002020
|
| 7448 | VTN, V75, VN, VNT | vitronectin |
C00000208
|
| 31 | ACACA, ACAC, ACACAD, ACC, ACC1, ACCA | acetyl-CoA carboxylase alpha (EC:6.4.1.2 6.3.4.14) |
C00000209
|
| 6364 | CCL20, CKb4, LARC, MIP-3-alpha, MIP-3a, MIP3A, SCYA20, ST38 | chemokine (C-C motif) ligand 20 |
C00000209
|
| 57491 | AHRR, AHH, AHHR, bHLHe77 | aryl-hydrocarbon receptor repressor |
C00002020
|
| 51268 | PIPOX, LPIPOX | pipecolic acid oxidase (EC:1.5.3.1 1.5.3.7) |
C00001387
|
| 2152 | F3, CD142, TF, TFA | coagulation factor III (thromboplastin, tissue factor) |
C00000209
|
| 389692 | MAFA, RIPE3b1, hMafA | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A |
C00000209
|
| 4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase |
C00000209
|
| 2475 | MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1 | mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) |
C00000209
|
| 4967 | OGDH, AKGDH, E1k, OGDC | oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) (EC:1.2.4.2) |
C00000209
|
| 5562 | PRKAA1, AMPK, AMPKa1 | protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31) |
C00000209
|
| 6194 | RPS6, S6 | ribosomal protein S6 |
C00000209
|
| 22933 | SIRT2, SIR2, SIR2L, SIR2L2 | sirtuin 2 (EC:3.5.1.-) |
C00000209
|
| 57192 | MCOLN1, MG-2, ML4, MLIV, MST080, TRP-ML1, TRPM-L1, TRPML1 | mucolipin 1 |
C00007537
|
| 9625 | AATK, AATYK, AATYK1, LMR1, LMTK1, p35BP | apoptosis-associated tyrosine kinase (EC:2.7.11.1) |
C00002057
|
| 153 | ADRB1, ADRB1R, B1AR, BETA1AR, RHR | adrenoceptor beta 1 |
C00002057
|
| 154 | ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR | adrenoceptor beta 2, surface |
C00002057
|
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00002057
|
| 210 | ALAD, ALADH, PBGS | aminolevulinate dehydratase (EC:4.2.1.24) |
C00002057
|
| 240 | ALOX5, 5-LO, 5-LOX, 5LPG, LOG5 | arachidonate 5-lipoxygenase (EC:1.13.11.34) |
C00002057
|
| 262 | AMD1, ADOMETDC, AMD, SAMDC | adenosylmethionine decarboxylase 1 (EC:4.1.1.50) |
C00002057
|
| 269 | AMHR2, AMHR, MISR2, MISRII, MRII | anti-Mullerian hormone receptor, type II (EC:2.7.11.30) |
C00002057
|
| 327 | APEH, AARE, ACPH, APH, D3F15S2, D3S48E, DNF15S2, OPH | acylaminoacyl-peptide hydrolase (EC:3.4.19.1) |
C00002057
|
| 55082 | ARGLU1 | arginine and glutamate rich 1 |
C00002057
|
| 8874 | ARHGEF7, BETA-PIX, COOL-1, COOL1, Nbla10314, P50, P50BP, P85, P85COOL1, P85SPR, PAK3, PIXB | Rho guanine nucleotide exchange factor (GEF) 7 |
C00002057
|
| 408 | ARRB1, ARB1, ARR1 | arrestin, beta 1 |
C00002057
|
| 546 | ATRX, ATR2, JMS, MRXHF1, RAD54, RAD54L, SFM1, SHS, XH2, XNP, ZNF-HX | alpha thalassemia/mental retardation syndrome X-linked (EC:3.6.4.12) |
C00002057
|
| 572 | BAD, BBC2, BCL2L8 | BCL2-associated agonist of cell death |
C00002057
|
| 597 | BCL2A1, ACC-1, ACC-2, BCL2L5, BFL1, GRS, HBPA1 | BCL2-related protein A1 |
C00002057
|
| 632 | BGLAP, BGP, OC, OCN | bone gamma-carboxyglutamate (gla) protein |
C00002057
|
| 329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00002057
|
| 332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00002057
|
| 648 | BMI1, FLVI2/BMI1, PCGF4, RNF51 | BMI1 polycomb ring finger oncogene |
C00002057
|
| 689 | BTF3, BETA-NAC, BTF3a, BTF3b, NACB | basic transcription factor 3 |
C00002057
|
| 695 | BTK, AGMX1, AT, ATK, BPK, IMD1, PSCTK1, XLA | Bruton agammaglobulinemia tyrosine kinase (EC:2.7.10.2) |
C00002057
|
| 728 | C5AR1, C5A, C5AR, C5R1, CD88 | complement component 5a receptor 1 |
C00002057
|
| 730 | C7 | complement component 7 |
C00002057
|
| 811 | CALR, CRT, RO, SSA, cC1qR | calreticulin |
C00002057
|
| 830 | CAPZA2, CAPPA2, CAPZ | capping protein (actin filament) muscle Z-line, alpha 2 |
C00002057
|
| 834 | CASP1, ICE, IL1BC, P45 | caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) |
C00002057
|
| 867 | CBL, C-CBL, CBL2, FRA11B, NSLL, RNF55 | Cbl proto-oncogene, E3 ubiquitin protein ligase |
C00002057
|
| 11335 | CBX3, HECH, HP1-GAMMA, HP1Hs-gamma | chromobox homolog 3 |
C00002057
|
| 6360 | CCL16, CKb12, HCC-4, ILINCK, LCC-1, LEC, LMC, Mtn-1, NCC-4, NCC4, SCYA16, SCYL4 | chemokine (C-C motif) ligand 16 |
C00002057
|
| 891 | CCNB1, CCNB | cyclin B1 |
C00002057
|
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00002057
|
| 894 | CCND2, KIAK0002 | cyclin D2 |
C00002057
|
| 901 | CCNG2 | cyclin G2 |
C00002057
|
| 1235 | CCR6, BN-1, C-C_CKR-6, CC-CKR-6, CCR-6, CD196, CKR-L3, CKRL3, CMKBR6, DCR2, DRY6, GPR29, GPRCY4, STRL22 | chemokine (C-C motif) receptor 6 |
C00002057
|
| 9973 | CCS | copper chaperone for superoxide dismutase |
C00002057
|
| 920 | CD4, CD4mut | CD4 molecule |
C00002057
|
| 4179 | CD46, AHUS2, MCP, MIC10, TLX, TRA2.10 | CD46 molecule, complement regulatory protein |
C00002057
|
| 966 | CD59, 16.3A5, 1F5, EJ16, EJ30, EL32, G344, HRF-20, HRF20, MAC-IP, MACIF, MEM43, MIC11, MIN1, MIN2, MIN3, MIRL, MSK21, p18-20 | CD59 molecule, complement regulatory protein |
C00002057
|
| 993 | CDC25A, CDC25A2 | cell division cycle 25A (EC:3.1.3.48) |
C00002057
|
| 8621 | CDK13, CDC2L, CDC2L5, CHED, hCDK13 | cyclin-dependent kinase 13 (EC:2.7.11.23 2.7.11.22) |
C00002057
|
| 1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00002057
|
| 1021 | CDK6, PLSTIRE | cyclin-dependent kinase 6 (EC:2.7.11.22) |
C00002057
|
| 1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00002057
|
| 1051 | CEBPB, C/EBP-beta, CRP2, IL6DBP, LAP, LIP, NF-IL6, TCF5 | CCAAT/enhancer binding protein (C/EBP), beta |
C00002057
|
| 1062 | CENPE, CENP-E, KIF10, PPP1R61 | centromere protein E, 312kDa |
C00002057
|
| 1106 | CHD2, EEOC | chromodomain helicase DNA binding protein 2 (EC:3.6.4.12) |
C00002057
|
| 1135 | CHRNA2 | cholinergic receptor, nicotinic, alpha 2 (neuronal) |
C00002057
|
| 1136 | CHRNA3, LNCR2, NACHRA3, PAOD2 | cholinergic receptor, nicotinic, alpha 3 (neuronal) |
C00002057
|
| 8973 | CHRNA6, CHNRA6 | cholinergic receptor, nicotinic, alpha 6 (neuronal) |
C00002057
|
| 1143 | CHRNB4 | cholinergic receptor, nicotinic, beta 4 (neuronal) |
C00002057
|
| 1160 | CKMT2, SMTCK | creatine kinase, mitochondrial 2 (sarcomeric) (EC:2.7.3.2) |
C00002057
|
| 100196409 |
C00002057
|
||
| 1164 | CKS2, CKSHS2 | CDC28 protein kinase regulatory subunit 2 |
C00002057
|
| 23155 | CLCC1, MCLC | chloride channel CLIC-like 1 |
C00002057
|
| 1182 | CLCN3, CLC3, ClC-3 | chloride channel, voltage-sensitive 3 |
C00002057
|
| 1272 | CNTN1, F3, GP135 | contactin 1 |
C00002057
|
| 1382 | CRABP2, CRABP-II, RBP6 | cellular retinoic acid binding protein 2 |
C00002057
|
| 1385 | CREB1, CREB | cAMP responsive element binding protein 1 |
C00002057
|
| 1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00002057
|
| 3579 | CXCR2, CD182, CDw128b, CMKAR2, IL8R2, IL8RA, IL8RB | chemokine (C-X-C motif) receptor 2 |
C00002057
|
| 2833 | CXCR3, CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R, Mig-R, MigR | chemokine (C-X-C motif) receptor 3 |
C00002057
|
| 54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00002057
|
| 1583 | CYP11A1, CYP11A, CYPXIA1, P450SCC | cytochrome P450, family 11, subfamily A, polypeptide 1 (EC:1.14.15.6) |
C00002057
|
| 1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00002057
|
| 1592 | CYP26A1, CP26, CYP26, P450RAI, P450RAI1 | cytochrome P450, family 26, subfamily A, polypeptide 1 (EC:1.14.-.-) |
C00002057
|
| 1553 | CYP2A13, CPAD, CYP2A, CYPIIA13 | cytochrome P450, family 2, subfamily A, polypeptide 13 (EC:1.14.14.1) |
C00002057
|
| 1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00002057
|
| 1555 | CYP2B6, CPB6, CYP2B, CYP2B7, CYP2B7P, CYPIIB6, EFVM, IIB1, P450 | cytochrome P450, family 2, subfamily B, polypeptide 6 (EC:1.14.14.1) |
C00002057
|
| 1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00002057
|
| 54876 | DCAF16, C4orf30 | DDB1 and CUL4 associated factor 16 |
C00002057
|
| 1642 | DDB1, DDBA, UV-DDB1, XAP1, XPCE, XPE, XPE-BF | damage-specific DNA binding protein 1, 127kDa |
C00002057
|
| 1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 |
C00002057
|
| 10521 | DDX17, P72, RH70 | DEAD (Asp-Glu-Ala-Asp) box helicase 17 (EC:3.6.4.13) |
C00002057
|
| 9191 | DEDD, CASP8IP1, DEDD1, DEFT, FLDED1 | death effector domain containing |
C00002057
|
| 1677 | DFFB, CAD, CPAN, DFF-40, DFF2, DFF40 | DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) |
C00002057
|
| 1719 | DHFR, DHFRP1, DYR | dihydrofolate reductase (EC:1.5.1.3) |
C00002057
|
| 1725 | DHPS, DHS, DS, MIG13 | deoxyhypusine synthase (EC:2.5.1.46) |
C00002057
|
| 1777 | DNASE2, DNASE2A, DNL, DNL2 | deoxyribonuclease II, lysosomal (EC:3.1.22.1) |
C00002057
|
| 10059 | DNM1L, DLP1, DRP1, DVLP, DYMPLE, EMPF, HDYNIV | dynamin 1-like (EC:3.6.5.5) |
C00002057
|
| 1841 | DTYMK, CDC8, PP3731, TMPK, TYMK | deoxythymidylate kinase (thymidylate kinase) (EC:2.7.4.9) |
C00002057
|
| 1783 | DYNC1LI2, DNCLI2, LIC2 | dynein, cytoplasmic 1, light intermediate chain 2 |
C00002057
|
| 1869 | E2F1, E2F-1, RBAP1, RBBP3, RBP3 | E2F transcription factor 1 |
C00002057
|
| 1870 | E2F2, E2F-2 | E2F transcription factor 2 |
C00002057
|
| 1871 | E2F3, E2F-3 | E2F transcription factor 3 |
C00002057
|
| 1874 | E2F4, E2F-4 | E2F transcription factor 4, p107/p130-binding |
C00002057
|
| 1875 | E2F5, E2F-5 | E2F transcription factor 5, p130-binding |
C00002057
|
| 1938 | EEF2, EEF-2, EF-2, EF2, SCA26 | eukaryotic translation elongation factor 2 |
C00002057
|
| 5610 | EIF2AK2, EIF2AK1, PKR, PRKR | eukaryotic translation initiation factor 2-alpha kinase 2 (EC:2.7.11.1 2.7.10.2) |
C00002057
|
| 27436 | EML4, C2orf2, ELP120, EMAP-4, EMAPL4, ROPP120 | echinoderm microtubule associated protein like 4 |
C00002057
|
| 2042 | EPHA3, EK4, ETK, ETK1, HEK, HEK4, TYRO4 | EPH receptor A3 (EC:2.7.10.1) |
C00002057
|
| 2049 | EPHB3, ETK2, HEK2, TYRO6 | EPH receptor B3 (EC:2.7.10.1) |
C00002057
|
| 2056 | EPO, EP, MVCD2 | erythropoietin |
C00002057
|
| 2147 | F2, PT, RPRGL2, THPH1 | coagulation factor II (thrombin) (EC:3.4.21.5) |
C00002057
|
| 356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00002057
|
| 2195 | FAT1, CDHF7, CDHR8, FAT, ME5, hFat1 | FAT atypical cadherin 1 |
C00002057
|
| 9638 | FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) |
C00002057
|
| 2322 | FLT3, CD135, FLK-2, FLK2, STK1 | fms-related tyrosine kinase 3 (EC:2.7.10.1) |
C00002057
|
| 2328 | FMO3, FMOII, TMAU, dJ127D3.1 | flavin containing monooxygenase 3 (EC:1.14.13.8 1.14.13.148) |
C00002057
|
| 2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00002057
|
| 2348 | FOLR1, FBP, FOLR | folate receptor 1 (adult) |
C00002057
|
| 2308 | FOXO1, FKH1, FKHR, FOXO1A | forkhead box O1 |
C00002057
|
| 2534 | FYN, SLK, SYN, p59-FYN | FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2) |
C00002057
|
| 2582 | GALE, SDR1E1 | UDP-galactose-4-epimerase (EC:5.1.3.2) |
C00002057
|
| 2624 | GATA2, DCML, MONOMAC, NFE1B | GATA binding protein 2 |
C00002057
|
| 2643 | GCH1, DYT14, DYT5, DYT5a, GCH, GTP-CH-1, GTPCH1, HPABH4B | GTP cyclohydrolase 1 (EC:3.5.4.16) |
C00002057
|
| 2657 | GDF1, DORV, DTGA3, RAI | growth differentiation factor 1 |
C00002057
|
| 11010 | GLIPR1, CRISP7, GLIPR, RTVP1 | GLI pathogenesis-related 1 |
C00002057
|
| 2790 | GNG10 | guanine nucleotide binding protein (G protein), gamma 10 |
C00002057
|
| 2803 | GOLGA4, GCP2, GOLG, MU-RMS-40.18, p230 | golgin A4 |
C00002057
|
| 2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) |
C00002057
|
| 30206 |
C00002057
|
||
| 2931 | GSK3A | glycogen synthase kinase 3 alpha (EC:2.7.11.1 2.7.11.26) |
C00002057
|
| 2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00002057
|
| 2978 | GUCA1A, C6orf131, COD3, CORD14, GCAP, GCAP1, GUCA, GUCA1, dJ139D8.6 | guanylate cyclase activator 1A (retina) |
C00002057
|
| 3094 | HINT1, HINT, NMAN, PKCI-1, PRKCNH1 | histidine triad nucleotide binding protein 1 |
C00002057
|
| 6596 | HLTF, HIP116, HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3, ZBU1 | helicase-like transcription factor |
C00002057
|
| 3159 | HMGA1, HMG-R, HMGA1A, HMGIY | high mobility group AT-hook 1 |
C00002057
|
| 3156 | HMGCR, LDLCQ3 | 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
C00002057
|
| 50809 | HP1BP3, HP1-BP74 | heterochromatin protein 1, binding protein 3 |
C00002057
|
| 3320 | HSP90AA1, EL52, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
C00002057
|
| 3422 | IDI1, IPP1, IPPI1 | isopentenyl-diphosphate delta isomerase 1 (EC:5.3.3.2) |
C00002057
|
| 2537 | IFI6, 6-16, FAM14C, G1P3, IFI-6-16, IFI616 | interferon, alpha-inducible protein 6 |
C00002057
|
| 3454 | IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC | interferon (alpha, beta and omega) receptor 1 |
C00002057
|
| 3507 |
C00002057
|
||
| 3552 | IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1 | interleukin 1, alpha |
C00002057
|
| 3563 | IL3RA, CD123, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra | interleukin 3 receptor, alpha (low affinity) |
C00002057
|
| 3574 | IL7, IL-7 | interleukin 7 |
C00002057
|
| 3578 | IL9, HP40, IL-9, P40 | interleukin 9 |
C00002057
|
| 3638 | INSIG1, CL-6, CL6 | insulin induced gene 1 |
C00002057
|
| 3674 | ITGA2B, BDPLT16, BDPLT2, CD41, CD41B, GP2B, GPIIb, GT, GTA, HPA3 | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
C00002057
|
| 3683 | ITGAL, CD11A, LFA-1, LFA1A | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
C00002057
|
| 3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
C00002057
|
| 3690 | ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
C00002057
|
| 3713 | IVL | involucrin |
C00002057
|
| 80853 | KDM7A, JHDM1D | lysine (K)-specific demethylase 7A |
C00002057
|
| 8462 | KLF11, FKLF, FKLF1, MODY7, TIEG2, Tieg3 | Kruppel-like factor 11 |
C00002057
|
| 58508 | KMT2C, HALR, MLL3 | lysine (K)-specific methyltransferase 2C (EC:2.1.1.43) |
C00002057
|
| 3932 | LCK, LSK, YT16, p56lck, pp58lck | lymphocyte-specific protein tyrosine kinase (EC:2.7.10.2) |
C00002057
|
| 3936 | LCP1, CP64, L-PLASTIN, LC64P, LPL, PLS2 | lymphocyte cytosolic protein 1 (L-plastin) |
C00002057
|
| 3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor |
C00002057
|
| 3981 | LIG4 | ligase IV, DNA, ATP-dependent (EC:6.5.1.1) |
C00002057
|
| 9516 | LITAF, PIG7, SIMPLE, TP53I7 | lipopolysaccharide-induced TNF factor |
C00002057
|
| 9208 | LRRFIP1, FLAP-1, FLAP1, FLIIAP1, GCF-2, GCF2, HUFI-1, TRIP | leucine rich repeat (in FLII) interacting protein 1 |
C00002057
|
| 4050 | LTB, TNFC, TNFSF3, p33 | lymphotoxin beta (TNF superfamily, member 3) |
C00002057
|
| 116068 | LYSMD3 | LysM, putative peptidoglycan-binding, domain containing 3 |
C00002057
|
| 8567 | MADD, DENN, IG20, RAB3GEP | MAP-kinase activating death domain |
C00002057
|
| 378938 | MALAT1, HCN, LINC00047, MALAT-1, NCRNA00047, NEAT2, PRO2853 | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) |
C00002057
|
| 5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00002057
|
| 4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00002057
|
| 80306 | MED28, 1500003D12Rik, EG1, magicin | mediator complex subunit 28 |
C00002057
|
| 4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) |
C00002057
|
| 4322 | MMP13, CLG3, MANDP1 | matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) |
C00002057
|
| 4314 | MMP3, CHDS6, MMP-3, SL-1, STMY, STMY1, STR1 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) |
C00002057
|
| 4316 | MMP7, MMP-7, MPSL1, PUMP-1 | matrix metallopeptidase 7 (matrilysin, uterine) (EC:3.4.24.23) |
C00002057
|
| 4485 | MST1, D3F15S2, DNF15S2, HGFL, MSP, NF15S2 | macrophage stimulating 1 (hepatocyte growth factor-like) |
C00002057
|
| 4528 | MTIF2 | mitochondrial translational initiation factor 2 |
C00002057
|
| 4605 | MYBL2, B-MYB, BMYB | v-myb avian myeloblastosis viral oncogene homolog-like 2 |
C00002057
|
| 4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00002057
|
| 4637 | MYL6, ESMLC, LC17, LC17-GI, LC17-NM, LC17A, LC17B, MLC-3, MLC1SM, MLC3NM, MLC3SM | myosin, light chain 6, alkali, smooth muscle and non-muscle |
C00002057
|
| 79923 | NANOG | Nanog homeobox |
C00002057
|
| 4698 | NDUFA5, B13, CI-13KD-B, CI-13kB, NUFM, UQOR13 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 (EC:1.6.5.3 1.6.99.3) |
C00002057
|
| 4773 | NFATC2, NFAT1, NFATP | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
C00002057
|
| 4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00002057
|
| 4794 | NFKBIE, IKBE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
C00002057
|
| 51199 | NIN, SCKL7 | ninein (GSK3B interacting protein) |
C00002057
|
| 4832 | NME3, DR-nm23, NDPK-C, NDPKC, NM23-H3, NM23H3, c371H6.2 | NME/NM23 nucleoside diphosphate kinase 3 (EC:2.7.4.6) |
C00002057
|
| 4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00002057
|
| 8473 | OGT, HRNT1, O-GLCNAC | O-linked N-acetylglucosamine (GlcNAc) transferase (EC:2.4.1.255) |
C00002057
|
| 4986 | OPRK1, K-OR-1, KOR, KOR-1, OPRK | opioid receptor, kappa 1 |
C00002057
|
| 4999 | ORC2, ORC2L | origin recognition complex, subunit 2 |
C00002057
|
| 79646 | PANK3 | pantothenate kinase 3 (EC:2.7.1.33) |
C00002057
|
| 5071 | PARK2, AR-JP, LPRS2, PDJ, PRKN | parkin RBR E3 ubiquitin protein ligase |
C00002057
|
| 3355109 |
C00002057
|
||
| 5155 | PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis | platelet-derived growth factor beta polypeptide |
C00002057
|
| 5159 | PDGFRB, CD140B, IBGC4, IMF1, JTK12, PDGFR, PDGFR-1, PDGFR1 | platelet-derived growth factor receptor, beta polypeptide (EC:2.7.10.1) |
C00002057
|
| 51317 | PHF21A, BHC80 | PHD finger protein 21A |
C00002057
|
| 23469 | PHF3 | PHD finger protein 3 |
C00002057
|
| 35178 |
C00002057
|
||
| 5281 | PIGF | phosphatidylinositol glycan anchor biosynthesis, class F (EC:2.7.8.1) |
C00002057
|
| 5290 | PIK3CA, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, p110-alpha | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153) |
C00002057
|
| 5586 | PKN2, PAK2, PRK2, PRKCL2, PRO2042, Pak-2 | protein kinase N2 (EC:2.7.11.13) |
C00002057
|
| 5327 | PLAT, T-PA, TPA | plasminogen activator, tissue (EC:3.4.21.68) |
C00002057
|
| 5328 | PLAU, ATF, BDPLT5, QPD, UPA, URK, u-PA | plasminogen activator, urokinase (EC:3.4.21.73) |
C00002057
|
| 5329 | PLAUR, CD87, U-PAR, UPAR, URKR | plasminogen activator, urokinase receptor |
C00002057
|
| 5337 | PLD1 | phospholipase D1, phosphatidylcholine-specific (EC:3.1.4.4) |
C00002057
|
| 5338 | PLD2 | phospholipase D2 (EC:3.1.4.4) |
C00002057
|
| 57480 | PLEKHG1, ARHGEF41 | pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
C00002057
|
| 5409 | PNMT, PENT, PNMTase | phenylethanolamine N-methyltransferase (EC:2.1.1.28) |
C00002057
|
| 8228 | PNPLA4, DXS1283E, GS2, iPLA2eta | patatin-like phospholipase domain containing 4 (EC:3.1.1.3) |
C00002057
|
| 5445 | PON2 | paraoxonase 2 (EC:3.1.1.2 3.1.1.81) |
C00002057
|
| 5450 | POU2AF1, BOB1, OBF-1, OBF1, OCAB | POU class 2 associating factor 1 |
C00002057
|
| 5451 | POU2F1, OCT1, OTF1, oct-1B | POU class 2 homeobox 1 |
C00002057
|
| 5460 | POU5F1, OCT3, OCT4, OTF-3, OTF3, OTF4, Oct-3, Oct-4 | POU class 5 homeobox 1 |
C00002057
|
| 5523 | PPP2R3A, PPP2R3, PR130, PR72 | protein phosphatase 2, regulatory subunit B'', alpha (EC:3.1.3.16) |
C00002057
|
| 5577 | PRKAR2B, PRKAR2, RII-BETA | protein kinase, cAMP-dependent, regulatory, type II, beta (EC:2.7.11.1) |
C00002057
|
| 5578 | PRKCA, AAG6, PKC-alpha, PKCA, PRKACA | protein kinase C, alpha (EC:2.7.11.13) |
C00002057
|
| 5589 | PRKCSH, AGE-R2, G19P1, PCLD, PKCSH, PLD1 | protein kinase C substrate 80K-H (EC:2.7.11.1) |
C00002057
|
| 5590 | PRKCZ, PKC-ZETA, PKC2 | protein kinase C, zeta (EC:2.7.11.13) |
C00002057
|
| 55119 | PRPF38B, NET1, RP11-293A10.1 | pre-mRNA processing factor 38B |
C00002057
|
| 23215 | PRRC2C, BAT2-iso, BAT2D1, BAT2L2, XTP2 | proline-rich coiled-coil 2C |
C00002057
|
| 5644 | PRSS1, TRP1, TRY1, TRY4, TRYP1 | protease, serine, 1 (trypsin 1) (EC:3.4.21.4) |
C00002057
|
| 5694 | PSMB6, DELTA, LMPY, Y | proteasome (prosome, macropain) subunit, beta type, 6 (EC:3.4.25.1) |
C00002057
|
| 5724 | PTAFR, PAFR | platelet-activating factor receptor |
C00002057
|
| 58155 | PTBP2, PTB, PTBLP, brPTB, nPTB, nPTB5, nPTB6, nPTB7, nPTB8 | polypyrimidine tract binding protein 2 |
C00002057
|
| 5806 | PTX3, TNFAIP5, TSG-14 | pentraxin 3, long |
C00002057
|
| 5870 | RAB6A, RAB6 | RAB6A, member RAS oncogene family |
C00002057
|
| 2741 | GLRA1, HKPX1, STHE | glycine receptor, alpha 1 |
C00002277
|
| 5916 | RARG, NR1B3, RARC | retinoic acid receptor, gamma |
C00002057
|
| 5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00002057
|
| 5930 | RBBP6, MY038, P2P-R, PACT, RBQ-1, SNAMA | retinoblastoma binding protein 6 |
C00002057
|
| 146713 | RBFOX3, FOX-3, FOX3, HRNBP3, NEUN | RNA binding protein, fox-1 homolog (C. elegans) 3 |
C00002057
|
| 5933 | RBL1, CP107, PRB1, p107 | retinoblastoma-like 1 (p107) |
C00002057
|
| 5934 | RBL2, P130, Rb2 | retinoblastoma-like 2 (p130) |
C00002057
|
| 58517 | RBM25, NET52, RED120, RNPC7, S164, Snu71, fSAP94 | RNA binding motif protein 25 |
C00002057
|
| 5994 | RFXAP | regulatory factor X-associated protein |
C00002057
|
| 5996 | RGS1, 1R20, BL34, IER1, IR20 | regulator of G-protein signaling 1 |
C00002057
|
| 6018 | RLF, ZN-15L, ZNF292L | rearranged L-myc fusion |
C00002057
|
| 6130 | RPL7A, L7A, SURF3, TRUP | ribosomal protein L7a |
C00002057
|
| 6230 | RPS25, S25 | ribosomal protein S25 |
C00002057
|
| 57521 | RPTOR, KOG1, Mip1 | regulatory associated protein of MTOR, complex 1 |
C00002057
|
| 862 | RUNX1T1, AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
C00002057
|
| 6281 | S100A10, 42C, ANX2L, ANX2LG, CAL1L, CLP11, Ca[1], GP11, P11, p10 | S100 calcium binding protein A10 |
C00002057
|
| 44263 |
C00002057
|
||
| 66234 |
C00002057
|
||
| 9169 | SCAF11, CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP | SR-related CTD-associated factor 11 |
C00002057
|
| 23480 | SEC61G, SSS1 | Sec61 gamma subunit |
C00002057
|
| 10955 | SERINC3, AIGP1, DIFF33, SBBI99, TDE, TDE1, TMS-1 | serine incorporator 3 |
C00002057
|
| 871 | SERPINH1, AsTP3, CBP1, CBP2, HSP47, OI10, PPROM, RA-A47, SERPINH2, gp46 | serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
C00002057
|
| 51639 | SF3B14, HSPC175, Ht006, P14, SAP14, SF3B14a | splicing factor 3B, 14 kDa subunit |
C00002057
|
| 10572 | SIVA1, CD27BP, SIVA, Siva-1, Siva-2 | SIVA1, apoptosis-inducing factor |
C00002057
|
| 6573 | SLC19A1, CHMD, FOLT, IFC1, REFC, RFC1 | solute carrier family 19 (folate transporter), member 1 |
C00002057
|
| 10559 | SLC35A1, CDG2F, CMPST, CST, hCST | solute carrier family 35 (CMP-sialic acid transporter), member A1 |
C00002057
|
| 25800 | SLC39A6, LIV-1 | solute carrier family 39 (zinc transporter), member 6 |
C00002057
|
| 9351 | SLC9A3R2, E3KARP, NHE3RF2, NHERF-2, NHERF2, OCTS2, SIP-1, SIP1, TKA-1 | solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 |
C00002057
|
| 4093 | SMAD9, MADH6, MADH9, PPH2, SMAD8, SMAD8A, SMAD8B | SMAD family member 9 |
C00002057
|
| 6615 | SNAI1, SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1 | snail family zinc finger 1 |
C00002057
|
| 6591 | SNAI2, SLUG, SLUGH1, SNAIL2, WS2D | snail family zinc finger 2 |
C00002057
|
| 6619 | SNAPC3, PTFbeta, SNAP50 | small nuclear RNA activating complex, polypeptide 3, 50kDa |
C00002057
|
| 252672 |
C00002057
|
||
| 6654 | SOS1, GF1, GGF1, GINGF, HGF, NS4 | son of sevenless homolog 1 (Drosophila) |
C00002057
|
| 9043 | SPAG9, CT89, HLC-6, HLC4, JIP-4, JIP4, JLP, PHET, PIG6 | sperm associated antigen 9 |
C00002057
|
| 6696 | SPP1, BNSP, BSPI, ETA-1, OPN | secreted phosphoprotein 1 |
C00002057
|
| 6714 | SRC, ASV, SRC1, c-SRC, p60-Src | v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (EC:2.7.10.2) |
C00002057
|
| 400410 | ST20, HCCS-1 | suppressor of tumorigenicity 20 |
C00002057
|
| 6770 | STAR, STARD1 | steroidogenic acute regulatory protein |
C00002057
|
| 6773 | STAT2, ISGF-3, P113, STAT113 | signal transducer and activator of transcription 2, 113kDa |
C00002057
|
| 6777 | STAT5B, STAT5 | signal transducer and activator of transcription 5B |
C00002057
|
| 6778 | STAT6, D12S1644, IL-4-STAT, STAT6B, STAT6C | signal transducer and activator of transcription 6, interleukin-4 induced |
C00002057
|
| 8614 | STC2, STC-2, STCRP | stanniocalcin 2 |
C00002057
|
| 10963 | STIP1, HOP, IEF-SSP-3521, P60, STI1, STI1L | stress-induced-phosphoprotein 1 |
C00002057
|
| 10494 | STK25, SOK1, YSK1 | serine/threonine kinase 25 (EC:2.7.11.1) |
C00002057
|
| 6814 | STXBP3, MUNC18-3, MUNC18C, PSP, UNC-18C | syntaxin binding protein 3 |
C00002057
|
| 6827 | SUPT4H1, SPT4, SPT4H, SUPT4H | suppressor of Ty 4 homolog 1 (S. cerevisiae) |
C00002057
|
| 8407 | TAGLN2, HA1756 | transgelin 2 |
C00002057
|
| 57551 | TAOK1, KFC-B, MAP3K16, MARKK, PSK-2, PSK2, TAO1, hKFC-B, hTAOK1 | TAO kinase 1 (EC:2.7.11.1) |
C00002057
|
| 7027 | TFDP1, DP1, DRTF1, Dp-1 | transcription factor Dp-1 |
C00002057
|
| 7980 | TFPI2, PP5, REF1, TFPI-2 | tissue factor pathway inhibitor 2 |
C00002057
|
| 7054 | TH, DYT14, DYT5b, TYH | tyrosine hydroxylase (EC:1.14.16.2) |
C00002057
|
| 9984 | THOC1, HPR1, P84, P84N5 | THO complex 1 |
C00002057
|
| 7078 | TIMP3, HSMRK222, K222, K222TA2, SFD | TIMP metallopeptidase inhibitor 3 |
C00002057
|
| 7079 | TIMP4 | TIMP metallopeptidase inhibitor 4 |
C00002057
|
| 7082 | TJP1, ZO-1 | tight junction protein 1 |
C00002057
|
| 440026 | TMEM41B | transmembrane protein 41B |
C00002057
|
| 7132 | TNFRSF1A, CD120a, FPF, MS5, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR1-d2, TNFR55, TNFR60, p55, p55-R, p60 | tumor necrosis factor receptor superfamily, member 1A |
C00002057
|
| 11073 | TOPBP1, TOP2BP1 | topoisomerase (DNA) II binding protein 1 |
C00002057
|
| 7175 | TPR | translocated promoter region, nuclear basket protein |
C00002057
|
| 29896 | TRA2A, AWMS1, HSU53209 | transformer 2 alpha homolog (Drosophila) |
C00002057
|
| 28951 | TRIB2, C5FW, GS3955, TRB2 | tribbles pseudokinase 2 |
C00002057
|
| 9321 | TRIP11, ACG1A, CEV14, GMAP-210, TRIP-11, TRIP230 | thyroid hormone receptor interactor 11 |
C00002057
|
| 7253 | TSHR, CHNG1, LGR3, hTSHR-I | thyroid stimulating hormone receptor |
C00002057
|
| 203068 | TUBB, M40, OK/SW-cl.56, TUBB1, TUBB5 | tubulin, beta class I |
C00002057
|
| 7291 | TWIST1, ACS3, BPES2, BPES3, CRS1, SCS, TWIST, bHLHa38 | twist family bHLH transcription factor 1 |
C00002057
|
| 10190 | TXNDC9, APACD, PHLP3 | thioredoxin domain containing 9 |
C00002057
|
| 23350 | U2SURP, SR140, fSAPa | U2 snRNP-associated SURP domain containing |
C00002057
|
| 10054 | UBA2, ARX, SAE2 | ubiquitin-like modifier activating enzyme 2 |
C00002057
|
| 11065 | UBE2C, UBCH10, dJ447F3.2 | ubiquitin-conjugating enzyme E2C (EC:6.3.2.19) |
C00002057
|
| 7337 | UBE3A, ANCR, AS, E6-AP, EPVE6AP, HPVE6A | ubiquitin protein ligase E3A (EC:6.3.2.19) |
C00002057
|
| 51569 | UFM1, BM-002, C13orf20 | ubiquitin-fold modifier 1 |
C00002057
|
| 7360 | UGP2, UDPG, UDPGP, UDPGP2, UGP1, UGPP1, UGPP2, pHC379 | UDP-glucose pyrophosphorylase 2 (EC:2.7.7.9) |
C00002057
|
| 54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00002057
|
| 54657 | UGT1A4, HUG-BR2, UDPGT, UDPGT_1-4, UGT-1D, UGT1-04, UGT1.4, UGT1D | UDP glucuronosyltransferase 1 family, polypeptide A4 (EC:2.4.1.17) |
C00002057
|
| 54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00002057
|
| 9094 | UNC119, HRG4, POC7, POC7A | unc-119 homolog (C. elegans) |
C00002057
|
| 7386 | UQCRFS1, RIP1, RIS1, RISP, UQCR5 | ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 (EC:1.10.2.2) |
C00002057
|
| 7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00002057
|
| 7431 | VIM, CTRCT30 | vimentin |
C00002057
|
| 331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00002057
|
| 7503 | XIST, DXS1089, DXS399E, LINC00001, NCRNA00001, SXI1, swd66 | X inactive specific transcript (non-protein coding) |
C00002057
|
| 7525 | YES1, HsT441, P61-YES, Yes, c-yes | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 (EC:2.7.10.2) |
C00002057
|
| 23318 | ZCCHC11, PAPD3, TUT4 | zinc finger, CCHC domain containing 11 (EC:2.7.7.52) |
C00002057
|
| 84240 | ZCCHC9, PPP1R41 | zinc finger, CCHC domain containing 9 |
C00002057
|
| 6935 | ZEB1, AREB6, BZP, DELTAEF1, FECD6, NIL2A, PPCD3, TCF8, ZFHEP, ZFHX1A | zinc finger E-box binding homeobox 1 |
C00002057
|
| 7538 | ZFP36, G0S24, GOS24, NUP475, RNF162A, TIS11, TTP, zfp-36 | ZFP36 ring finger protein |
C00002057
|
| 51663 | ZFR, ZFR1 | zinc finger RNA binding protein |
C00002057
|
| 23613 | ZMYND8, PRKCBP1, PRO2893, RACK7 | zinc finger, MYND-type containing 8 |
C00002057
|
| 7705 | ZNF146, OZF | zinc finger protein 146 |
C00002057
|
| 100129482 | ZNF37BP, KOX21, ZNF37B | zinc finger protein 37B, pseudogene |
C00002057
|
| 90333 | ZNF468 | zinc finger protein 468 |
C00002057
|
| 100289635 | ZNF605 | zinc finger protein 605 |
C00002057
|
| 100129842 | ZNF737, ZNF102 | zinc finger protein 737 |
C00002057
|
| 1103 | CHAT, CHOACTASE, CMS1A, CMS1A2 | choline O-acetyltransferase (EC:2.3.1.6) |
C00002292
|
| 4012 | LNPEP, CAP, IRAP, P-LAP, PLAP | leucyl/cystinyl aminopeptidase (EC:3.4.11.3) |
C00002292
|
Related Diseases
Diseases related to proteins in ChEMBL interactions
OMIM (156)
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
| #103470 | Albinism, ocular, with sensorineural deafness |
O75030
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 |
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
| #210900 | Bloom syndrome; blm |
P54132
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| %606641 | Body mass index; bmi |
P37231
|
| #114480 | Breast cancer |
P38398
|
| #604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
| #300615 | Brunner syndrome |
P21397
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #212140 | Carnitine deficiency, systemic primary; cdsp |
O76082
|
| #609338 | Carotid intimal medial thickness 1 |
P37231
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #114500 | Colorectal cancer; crc |
P84022
|
| #162800 | Cyclic neutropenia |
P08246
|
| #127750 | Dementia, lewy body; dlb |
P37840
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #119900 | Digital clubbing, isolated congenital |
P15428
|
| #607208 | Dravet syndrome |
P35498
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #237500 | Dubin-johnson syndrome; djs |
Q92887
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #600513 | Epilepsy, nocturnal frontal lobe, 1; enfl1 |
P43681
|
| #605375 | Epilepsy, nocturnal frontal lobe, 3; enfl3 |
P17787
|
| #610353 | Epilepsy, nocturnal frontal lobe, 4; enfl4 |
Q15822
|
| #613721 | Epileptic encephalopathy, early infantile, 11; eiee11 |
Q99250
|
| #615040 | Episodic pain syndrome, familial, 1; feps1 |
O75762
|
| #609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
| #133239 | Esophageal cancer |
P04637
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #612219 | Ewing sarcoma; es |
P11308
|
| #301500 | Fabry disease |
P06280
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #230000 | Fucosidosis |
P04066
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #604403 | Generalized epilepsy with febrile seizures plus, type 2; gefsp2 |
P35498
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
| #232300 | Glycogen storage disease ii |
P10253
|
| #232400 | Glycogen storage disease iii |
P35573
|
| #232700 | Glycogen storage disease vi |
P06737
|
| #612933 | Glycogen storage disease xi; gsd11 |
P00338
|
| #230500 | Gm1-gangliosidosis, type i |
P16278
|
| #230600 | Gm1-gangliosidosis, type ii |
P16278
|
| #230650 | Gm1-gangliosidosis, type iii |
P16278
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #603373 | Hyperthyroidism, familial gestational |
P16473
|
| #609152 | Hyperthyroidism, nonautoimmune |
P16473
|
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
| #218700 | Hypothyroidism, congenital, nongoitrous, 2; chng2 |
Q06710
|
| #612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #223000 | Lactase deficiency, congenital |
P09848
|
| #151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
| #613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 P04637 |
| #608516 | Major depressive disorder; mdd |
P08172
|
| #611162 | Malaria, susceptibility to |
P05362
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #248500 | Mannosidosis, alpha b, lysosomal; mansa |
O00754
|
| #248510 | Mannosidosis, beta a, lysosomal; mansb |
O00462
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| #614456 | Melanoma, cutaneous malignant, susceptibility to, 8; cmm8 |
O75030
|
| #614202 | Mental retardation, autosomal recessive 15; mrt15 |
Q9UKM7
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #609634 | Migraine, familial hemiplegic, 3; fhm3 |
P35498
|
| #253010 | Mucopolysaccharidosis type ivb |
P16278
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #265000 | Multiple pterygium syndrome, escobar variant; evmps |
P07510
|
| #253290 | Multiple pterygium syndrome, lethal type; lmps |
P02708
P07510 Q07001 |
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #608931 | Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency |
P11230
|
| #254210 | Myasthenic syndrome, congenital, associated with episodic apnea |
P28329
|
| #608930 | Myasthenic syndrome, congenital, fast-channel |
P02708
Q07001 |
| #601462 | Myasthenic syndrome, congenital, slow-channel; sccms |
P02708
P11230 Q07001 |
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #159900 | Myoclonic dystonia |
P14416
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #257200 | Niemann-pick disease, type a |
P17405
|
| #607616 | Niemann-pick disease, type b |
P17405
|
| #257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
| #601665 | Obesity |
P32245
P37231 |
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
P38398 |
| #614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
| #260500 | Papilloma of choroid plexus; cpp |
P04637
|
| #168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
| #605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
P37840 |
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #172700 | Pick disease of brain |
P10636
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #180300 | Rheumatoid arthritis; ra |
Q9H015
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #607745 | Seizures, benign familial infantile, 3; bfis3 |
Q99250
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #612052 | Smoking as a quantitative trait locus 3; sqtl3 |
P30532
P32297 |
| #614409 | Spastic paraplegia 46, autosomal recessive; spg46 |
Q9HCG7
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
| #222900 | Sucrase-isomaltase deficiency, congenital; csid |
P14410
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
| #274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
| #145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
| #103500 | Tietz syndrome |
O75030
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
| #193510 | Waardenburg syndrome, type 2a; ws2a |
O75030
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #112100 | Yt blood group antigen |
P22303
|
KEGG DISEASE (133)
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00140 | beta-Mannosidosis |
O00462
(related)
|
| H00422 | Glycoproteinoses |
O00462
(related)
O00754 (related) P04066 (related) P16278 (related) |
| H00139 | alpha-Mannosidosis |
O00754
(related)
|
| H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
| H00038 | Malignant melanoma |
O75030
(related)
O75030 (marker) P04637 (related) |
| H00169 | Ocular albinism |
O75030
(related)
|
| H00759 | Waardenburg syndrome (WS) |
O75030
(related)
|
| H01187 | Tietz syndrome |
O75030
(related)
|
| H00286 | Crohn's disease |
O76082
(related)
Q9H015 (related) |
| H00525 | Disorders of fatty-acid oxidation |
O76082
(related)
|
| H00069 | Glycogen storage diseases (GSD) |
P00338
(related)
P06737 (related) P10253 (related) P35573 (related) |
| H00010 | Multiple myeloma |
P00338
(marker)
P04637 (related) |
| H00023 | Testicular cancer |
P00338
(marker)
|
| H00035 | Ewing's sarcoma |
P00338
(marker)
P11308 (related) |
| H00043 | Neuroblastoma |
P00338
(marker)
|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00770 | Congenital myasthenic syndrome |
P02708
(related)
P11230 (related) P28329 (related) Q07001 (related) |
| H00986 | Multiple pterygium syndrome |
P02708
(related)
P07510 (related) Q07001 (related) |
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
P37840 (related) |
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
P16278 (related) |
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00141 | Fucosidosis |
P04066
(related)
|
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
| H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) P38398 (related) |
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) P38398 (related) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
| H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
| H00006 | Hairy-cell leukemia |
P04637
(related)
|
| H00008 | Burkitt lymphoma |
P04637
(related)
|
| H00009 | Adult T-cell leukemia |
P04637
(related)
|
| H00013 | Small cell lung cancer |
P04637
(related)
|
| H00014 | Non-small cell lung cancer |
P04637
(related)
|
| H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
| H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
| H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
| H00029 | Vulvar cancer |
P04637
(related)
|
| H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) Q06710 (related) |
| H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
| H00039 | Basal cell carcinoma |
P04637
(related)
|
| H00040 | Squamous cell carcinoma |
P04637
(related)
|
| H00041 | Kaposi's sarcoma |
P04637
(related)
|
| H00044 | Cancer of the anal canal |
P04637
(related)
|
| H00047 | Gallbladder cancer |
P04637
(related)
|
| H00048 | Hepatocellular carcinoma |
P04637
(related)
|
| H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
| H01007 | Choroid plexus papilloma |
P04637
(related)
|
| H00021 | Renal cell carcinoma |
P04637
(marker)
|
| H00083 | Allograft rejection |
P05362
(related)
|
| H00080 | Systemic lupus erythematosus |
P05362
(marker)
|
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00125 | Fabry disease |
P06280
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00116 | Congenital lactase deficiency |
P09848
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
| H00024 | Prostate cancer |
P11308
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00115 | Congenital sucrase-isomaltase deficiency |
P14410
(related)
|
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
| H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
| H00123 | Mucopolysaccharidosis type IV (MPS4) |
P16278
(related)
|
| H00276 | Galactosialidosis |
P16278
(related)
|
| H00281 | GM1 gangliosidosis |
P16278
(related)
|
| H00421 | Mucopolysaccharidosis (MPS) |
P16278
(related)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
Q06710 (related) |
| H01269 | Congenital hyperthyroidism |
P16473
(related)
|
| H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
| H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
| H00807 | Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) |
P17787
(related)
P43681 (related) Q15822 (related) |
| H00548 | Brunner syndrome |
P21397
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00775 | Familial or sporadic hemiplegic migraine |
P35498
(related)
|
| H00783 | Febrile seizures |
P35498
(related)
|
| H00409 | Type II diabetes mellitus |
P37231
(related)
|
| H00057 | Parkinson's disease (PD) |
P37840
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
| H00094 | DNA repair defects |
P54132
(related)
|
| H00296 | Defects in RecQ helicases |
P54132
(related)
|
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
| H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
| H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
| H00208 | Hyperbilirubinemia |
Q92887
(related)
|
| H00606 | Early infantile epileptic encephalopathy |
Q99250
(related)
|
| H00806 | Benign familial neonatal and infantile epilepsies |
Q99250
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
| H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
Diseases related to CTD interactions
681 disease in interactions with metabolites
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D006948 | Hyperkinesis |
C00002056
C00002017 C00002015 C00002285 C00002053 C00000209 C00002057 C00002292 |
| D012640 | Seizures |
C00002280
C00002027 C00002277 C00002285 C00002053 C00000209 C00002057 C00002292 |
| D056486 | Drug-Induced Liver Injury |
C00002277
C00002285 C00007256 C00000208 C00000209 C00002057 C00002292 |
| D019970 | Cocaine-Related Disorders |
C00002291
C00002280 C00002277 C00002285 C00002053 C00002057 C00002292 |
| D006973 | Hypertension |
C00002277
C00002285 C00000208 C00000209 C00002057 C00002292 |
| D014202 | Tremor |
C00002015
C00002020 C00002277 C00002285 C00002057 C00002292 |
| D009203 | Myocardial Infarction |
C00002280
C00002277 C00002285 C00000208 C00002057 C00002292 |
| D014839 | Vomiting |
C00002277
C00002285 C00000208 C00002057 C00002292 |
| D009336 | Necrosis |
C00002277
C00002285 C00007256 C00000208 C00002057 |
| D009325 | Nausea |
C00002277
C00002285 C00000208 C00002057 C00002292 |
| D064420 | Drug-Related Side Effects and Adverse Reactions |
C00002277
C00002285 C00000208 C00000209 C00002057 |
| D003072 | Cognition Disorders |
C00002280
C00002285 C00000208 C00002057 C00002292 |
| D001919 | Bradycardia |
C00002020
C00002277 C00002285 C00002057 C00002292 |
| D009127 | Muscle Rigidity |
C00002020
C00002277 C00002285 C00000208 C00002292 |
| D007022 | Hypotension |
C00002020
C00002277 C00002285 C00000208 C00002057 |
| D002375 | Catalepsy |
C00002020
C00002277 C00002285 C00002057 C00002292 |
| D003693 | Delirium |
C00002277
C00002285 C00000208 C00002057 C00002292 |
| D007859 | Learning Disorders |
C00002277
C00002285 C00002057 C00002292 |
| D004244 | Dizziness |
C00002285
C00000208 C00002057 C00002292 |
| D007249 | Inflammation |
C00002277
C00002285 C00000208 C00002057 |
| D007035 | Hypothermia |
C00002277
C00002285 C00002057 C00002292 |
| D011183 | Postoperative Complications |
C00002277
C00002285 C00002057 C00002292 |
| D013375 | Substance Withdrawal Syndrome |
C00002277
C00002285 C00002057 C00002292 |
| D000647 | Amnesia |
C00002020
C00002277 C00002057 C00002292 |
| D013610 | Tachycardia |
C00002277
C00002285 C00002057 C00002292 |
| D009410 | Nerve Degeneration |
C00002285
C00000209 C00002057 C00002292 |
| D014786 | Vision Disorders |
C00002277
C00002285 C00000208 C00002292 |
| D001259 | Ataxia |
C00002015
C00002285 C00002057 C00002292 |
| D012120 | Respiration Disorders |
C00002280
C00002277 C00002285 C00002057 |
| D013226 | Status Epilepticus |
C00002020
C00002277 C00002285 C00002292 |
| D011297 | Prenatal Exposure Delayed Effects |
C00002280
C00002277 C00002285 C00002057 |
| D012021 | Reflex, Abnormal |
C00002277
C00002285 C00002057 C00002292 |
| D020521 | Stroke |
C00002285
C00000208 C00000209 C00002057 |
| D015428 | Myocardial Reperfusion Injury |
C00002285
C00000208 C00002057 |
| D001161 | Arteriosclerosis |
C00002285
C00000208 C00002057 |
| D001049 | Apnea |
C00002277
C00002285 C00002057 |
| D001145 | Arrhythmias, Cardiac |
C00002277
C00002285 C00002057 |
| D050197 | Atherosclerosis |
C00002285
C00000208 C00002057 |
| D001281 | Atrial Fibrillation |
C00002277
C00002285 C00002057 |
| D054537 | Atrioventricular Block |
C00002277
C00002285 C00002057 |
| D001943 | Breast Neoplasms |
C00002277
C00000208 C00002057 |
| D010146 | Pain |
C00002285
C00000208 C00002057 |
| D010190 | Pancreatic Neoplasms |
C00002285
C00000209 C00002057 |
| D002561 | Cerebrovascular Disorders |
C00002277
C00002285 C00002057 |
| D002637 | Chest Pain |
C00002277
C00002285 C00002057 |
| D003128 | COMA |
C00002277
C00002285 C00002292 |
| D003329 | Coronary Vasospasm |
C00002277
C00002285 C00002057 |
| D011507 | Proteinuria |
C00002285
C00000208 C00002057 |
| D009069 | Movement Disorders |
C00002285
C00002057 C00002292 |
| D003967 | Diarrhea |
C00002277
C00002285 C00002057 |
| D018476 | Hypokinesia |
C00000208
C00002057 C00002292 |
| D011595 | Psychomotor Agitation |
C00002285
C00002053 C00002292 |
| D008569 | Memory Disorders |
C00002285
C00002057 C00002292 |
| D011605 | Psychoses, Substance-Induced |
C00002285
C00002057 C00002292 |
| D012164 | Retinal Diseases |
C00002285
C00000208 C00002057 |
| D012798 | Sialorrhea |
C00002285
C00002057 C00002292 |
| D014987 | Xerostomia |
C00002277
C00002285 C00002292 |
| D007172 | Erectile Dysfunction |
C00002277
C00002285 C00002057 |
| D005334 | Fever |
C00002277
C00002285 C00002057 |
| D007634 | Keratitis |
C00002285
C00000208 C00002292 |
| D010243 | Paralysis |
C00002020
C00002277 C00002057 |
| D006212 | Hallucinations |
C00002277
C00002285 C00002292 |
| D006261 | Headache |
C00002277
C00002285 C00002057 |
| D006323 | Heart Arrest |
C00002277
C00002285 C00002057 |
| D001927 | Brain Diseases |
C00002285
C00002057 C00002292 |
| D001930 | Brain Injuries |
C00002285
C00002057 C00002292 |
| D013575 | Syncope |
C00002277
C00002285 C00000208 |
| D006943 | Hyperglycemia |
C00002277
C00000208 C00000209 |
| D019954 | Neurobehavioral Manifestations |
C00002020
C00002285 C00002057 |
| D005076 | Exanthema |
C00002285
C00000208 C00002057 |
| D002318 | Cardiovascular Diseases |
C00002285
C00000208 C00002057 |
| D004487 | Edema |
C00002285
C00000208 C00002057 |
| D013276 | Stomach Ulcer |
C00002277
C00002285 C00002057 |
| D004409 | Dyskinesia, Drug-Induced |
C00002285
C00002057 C00002292 |
| D008133 | Long QT Syndrome |
C00002277
C00002285 C00002057 |
| D012131 | Respiratory Insufficiency |
C00002277
C00002285 C00002057 |
| D020820 | Dyskinesias |
C00002020
C00002277 C00000208 |
| D014657 | Vasculitis |
C00002285
C00000209 C00002057 |
| D011654 | Pulmonary Edema |
C00002277
C00002285 C00002057 |
| D015878 | Mydriasis |
C00002277
C00002285 C00002292 |
| D017202 | Myocardial Ischemia |
C00002277
C00002285 C00000208 |
| D002972 | Cleft Palate |
C00002285
C00000208 C00000209 |
| D011041 | Poisoning |
C00002277
C00002285 C00002057 |
| D018908 | Muscle Weakness |
C00002015
C00002277 C00002285 |
| D003324 | Coronary Artery Disease |
C00002285
C00000208 C00002057 |
| D009422 | Nervous System Diseases |
C00002277
C00002285 C00002057 |
| D006330 | Heart Defects, Congenital |
C00002285
C00000209 |
| D014549 | Urinary Incontinence |
C00002285
C00002292 |
| D013927 | Thrombosis |
C00002285
C00002057 |
| D010554 | Personality Disorders |
C00002277
C00002285 |
| D014652 | Vascular Diseases |
C00002285
C00002057 |
| D009207 | Myoclonus |
C00002277
C00002057 |
| D020250 | Postoperative Nausea and Vomiting |
C00002277
C00002292 |
| D009157 | Myasthenia Gravis |
C00002277
C00002285 |
| D009135 | Muscular Diseases |
C00002277
C00000208 |
| D015431 | Weight Loss |
C00002285
C00002292 |
| D054138 | Sinus Arrest, Cardiac |
C00002277
C00002285 |
| D007410 | Intestinal Diseases |
C00002277
C00002285 |
| D053608 | Stupor |
C00002277
C00002292 |
| D007008 | Hypokalemia |
C00002277
C00002285 |
| D006940 | Hyperemia |
C00002277
C00002057 |
| D006342 | Heart Rupture, Post-Infarction |
C00002277
C00002285 |
| D013919 | Thromboangiitis Obliterans |
C00002285
C00002057 |
| D013616 | Tachycardia, Sinus |
C00002277
C00002285 |
| D013617 | Tachycardia, Supraventricular |
C00002277
C00002285 |
| D017180 | Tachycardia, Ventricular |
C00002277
C00002285 |
| D016171 | Torsades de Pointes |
C00002277
C00002285 |
| D013398 | Sudden Infant Death |
C00002285
C00002057 |
| D019966 | Substance-Related Disorders |
C00002285
C00002057 |
| D013345 | Subarachnoid Hemorrhage |
C00002285
C00002057 |
| D006327 | Heart Block |
C00002277
C00002292 |
| D014693 | Ventricular Fibrillation |
C00002277
C00002285 |
| D005767 | Gastrointestinal Diseases |
C00002277
C00000208 |
| D005483 | Flushing |
C00002277
C00000208 |
| D004830 | Epilepsy, Tonic-Clonic |
C00002277
C00002285 |
| D019956 | Stereotypic Movement Disorder |
C00002285
C00002057 |
| D015746 | Abdominal Pain |
C00002285
C00002057 |
| D000014 | Abnormalities, Drug-Induced |
C00002285
C00002057 |
| D013035 | Spasm |
C00002285
C00002057 |
| D007319 | Sleep Initiation and Maintenance Disorders |
C00002285
C00002057 |
| D012893 | Sleep Disorders |
C00002285
C00002057 |
| D012848 | Sinoatrial Block |
C00002285
C00002057 |
| D019969 | Amphetamine-Related Disorders |
C00002053
C00002057 |
| D000138 | Acidosis |
C00002285
C00000208 |
| D000544 | Alzheimer Disease |
C00000208
C00002057 |
| D058186 | Acute Kidney Injury |
C00002285
C00002057 |
| D015427 | Reperfusion Injury |
C00002285
C00002057 |
| D011693 | Purpura |
C00002285
C00002057 |
| D011681 | Pupil Disorders |
C00002285
C00002292 |
| D011618 | Psychotic Disorders |
C00002285
C00002057 |
| D004890 | Erythema |
C00000208
C00002057 |
| D011596 | Psychomotor Disorders |
C00002285
C00002292 |
| D062787 | Drug Overdose |
C00002277
C00002292 |
| D005234 | Fatty Liver |
C00000208
C00002057 |
| D011086 | Polycythemia |
C00002285
C00002057 |
| D011014 | Pneumonia |
C00002285
C00000208 |
| D016491 | Peripheral Vascular Diseases |
C00002285
C00002057 |
| D010510 | Periodontal Diseases |
C00002285
C00002057 |
| D010292 | Paresthesia |
C00002285
C00000208 |
| D017542 | Aneurysm, Ruptured |
C00002285
C00002057 |
| D010291 | Paresis |
C00002285
C00002057 |
| D010259 | Paranoid Disorders |
C00002285
C00002292 |
| D015875 | Anisocoria |
C00002285
C00002292 |
| D016584 | Panic Disorder |
C00002285
C00002057 |
| D006937 | Hypercholesterolemia |
C00000208
C00000209 |
| D001982 | Bronchial Diseases |
C00002277
C00002285 |
| D009669 | Nose Neoplasms |
C00002285
C00002057 |
| D001008 | Anxiety Disorders |
C00002285
C00002057 |
| D001014 | Aortic Aneurysm |
C00002285
C00002057 |
| D001018 | Aortic Diseases |
C00002285
C00002057 |
| D009436 | Neural Tube Defects |
C00002285
C00002057 |
| D001037 | Aphasia |
C00002285
C00002292 |
| D006951 | Hyperlipoproteinemias |
C00000208
C00000209 |
| D056988 | Anterior Wall Myocardial Infarction |
C00002277
C00002285 |
| D015228 | Hypertriglyceridemia |
C00000208
C00000209 |
| D001168 | Arthritis |
C00002285
C00002057 |
| D009133 | Muscular Atrophy |
C00002285
C00002057 |
| D000787 | Angina Pectoris |
C00002277
C00002285 |
| D052456 | Hypoalphalipoproteinemias |
C00000208
C00000209 |
| D008881 | Migraine Disorders |
C00002285
C00000208 |
| D007333 | Insulin Resistance |
C00000208
C00002057 |
| D008171 | Lung Diseases |
C00002285
C00002057 |
| D001289 | Attention Deficit Disorder with Hyperactivity |
C00002285
C00002057 |
| D001308 | Auditory Perceptual Disorders |
C00002285
C00002057 |
| D017114 | Liver Failure, Acute |
C00002285
C00000208 |
| D017880 | Limb Deformities, Congenital |
C00002285
C00000209 |
| D007805 | Language Development Disorders |
C00002285
C00002057 |
| D007676 | Kidney Failure, Chronic |
C00002285
C00000208 |
| D007674 | Kidney Diseases |
C00002285
C00000209 |
| D001714 | Bipolar Disorder |
C00002285
C00002057 |
| D055370 | Lung Injury |
C00000208
C00002292 |
| D007565 | Jaundice |
C00002285
C00000208 |
| D002546 | Ischemic Attack, Transient |
C00002285
C00000208 |
| D007511 | Ischemia |
C00002285
C00002057 |
| D002542 | Intracranial Embolism and Thrombosis |
C00002285
C00002057 |
| D007003 | Hypoglycemia |
C00002285
C00000208 |
| D006976 | Hypertension, Pulmonary |
C00002285
C00002057 |
| D009369 | Neoplasms |
C00000208
C00002057 |
| D001929 | Brain Edema |
C00002285
C00002057 |
| D010523 | Peripheral Nervous System Diseases |
C00000208
C00002057 |
| D002545 | Brain Ischemia |
C00002285
C00000209 |
| D006501 | Hepatic Encephalopathy |
C00002285
C00000208 |
| D020258 | Neurotoxicity Syndromes |
C00002277
C00002057 |
| D005402 | Fistula |
C00002285
C00002292 |
| D005317 | Fetal Growth Retardation |
C00002285
C00002057 |
| D005141 | Eyelid Diseases |
C00002285
C00000208 |
| D003221 | Confusion |
C00002285
C00002292 |
| D005117 | Cardiac Complexes, Premature |
C00002285
C00002057 |
| D005094 | Exophthalmos |
C00002285
C00000208 |
| D009202 | Cardiomyopathies |
C00002285
C00002057 |
| D009374 | Neoplasms, Experimental |
C00002020
C00002057 |
| D011537 | Pruritus |
C00000208
C00002057 |
| D003924 | Diabetes Mellitus, Type 2 |
C00000209
C00002057 |
| D002389 | Catatonia |
C00002285
C00002292 |
| D004421 | Dystonia |
C00002285
C00002057 |
| D006965 | Hyperplasia |
C00002020
C00002285 |
| D019636 | Neurodegenerative Diseases |
C00000209
C00002057 |
| D006970 | Disorders of Excessive Somnolence |
C00002285
C00002292 |
| D002543 | Cerebral Hemorrhage |
C00002285
C00002057 |
| D004195 | Disease Models, Animal |
C00002285
C00002292 |
| D002653 | Child Behavior Disorders |
C00002285
C00000209 |
| D023341 | Chills |
C00002285
C00000208 |
| D003866 | Depressive Disorder |
C00002285
C00002057 |
| D023921 | Coronary Stenosis |
C00002285
C00000208 |
| D003327 | Coronary Disease |
C00002285
C00000208 |
| D002971 | Cleft Lip |
C00002285
C00000208 |
| D009041 | Motion Sickness |
C00002057
C00002292 |
| D005879 | Tourette Syndrome |
C00002057
C00002292 |
| D003251 | Constriction, Pathologic |
C00002285
C00002057 |
| D005128 | Eye Diseases |
C00002285
C00000208 |
| D003117 | Color Vision Defects |
C00002285
|
| D003161 | Compartment Syndromes |
C00002285
|
| D003108 | Colonic Diseases |
C00002285
|
| D017091 | Colitis, Ischemic |
C00002285
|
| D003323 | Coronary Aneurysm |
C00002285
|
| D003027 | Cluster Headache |
C00002285
|
| D015267 | Churg-Strauss Syndrome |
C00002285
|
| D054059 | Coronary Occlusion |
C00002285
|
| D002869 | Chromosome Aberrations |
C00002285
|
| D003328 | Coronary Thrombosis |
C00002285
|
| D003371 | Cough |
C00002285
|
| D003389 | Cranial Nerve Diseases |
C00002285
|
| D003449 | Cryoglobulinemia |
C00002285
|
| D003556 | Cystitis |
C00002285
|
| D003560 | Cysts |
C00002285
|
| D003645 | Death, Sudden |
C00002285
|
| D016757 | Death, Sudden, Cardiac |
C00002285
|
| D003680 | Deglutition Disorders |
C00002285
|
| D003711 | Demyelinating Diseases |
C00002285
|
| D002819 | Chorea |
C00002285
|
| D002658 | Developmental Disabilities |
C00002285
|
| D003919 | Diabetes Insipidus |
C00002285
|
| D002544 | Cerebral Infarction |
C00002285
|
| D002526 | Cerebellar Diseases |
C00002285
|
| D004211 | Disseminated Intravascular Coagulation |
C00002285
|
| D002493 | Central Nervous System Diseases |
C00002285
|
| D003875 | Drug Eruptions |
C00002285
|
| D020863 | Central Nervous System Cysts |
C00002285
|
| D004417 | Dyspnea |
C00002285
|
| D002481 | Cellulitis |
C00002285
|
| D020215 | Carotid Artery, Internal, Dissection |
C00002285
|
| D020964 | Embryo Loss |
C00002285
|
| D004646 | Emphysema |
C00002285
|
| D004678 | Encephalomalacia |
C00002285
|
| D004673 | Encephalomyelitis, Acute Disseminated |
C00002285
|
| D004681 | Encephalomyelitis, Autoimmune, Experimental |
C00002285
|
| D004692 | Endarteritis |
C00002285
|
| D004696 | Endocarditis |
C00002285
|
| D009877 | Endophthalmitis |
C00002285
|
| D004751 | Enteritis |
C00002285
|
| D004760 | Enterocolitis |
C00002285
|
| D004844 | Epistaxis |
C00002285
|
| D002311 | Cardiomyopathy, Dilated |
C00002285
|
| D006332 | Cardiomegaly |
C00002285
|
| D005124 | Eye Abnormalities |
C00002285
|
| D002037 | Bundle-Branch Block |
C00002285
|
| D005130 | Eye Hemorrhage |
C00002285
|
| D018437 | Brown-Sequard Syndrome |
C00002285
|
| D005151 | Facial Injuries |
C00002285
|
| D005157 | Facial Pain |
C00002285
|
| D005221 | Fatigue |
C00002285
|
| D005315 | Fetal Diseases |
C00002285
|
| D005316 | Fetal Distress |
C00002285
|
| D001989 | Bronchiolitis Obliterans |
C00002285
|
| D005322 | Fetal Membranes, Premature Rupture |
C00002285
|
| D005352 | Fibromuscular Dysplasia |
C00002285
|
| D005355 | Fibrosis |
C00002285
|
| D005383 | Finger Injuries |
C00002285
|
| D001986 | Bronchial Spasm |
C00002285
|
| D021501 | Flank Pain |
C00002285
|
| D005759 | Gastroenteritis |
C00002285
|
| D006471 | Gastrointestinal Hemorrhage |
C00002285
|
| D020139 | Gastroschisis |
C00002285
|
| D005882 | Gingival Diseases |
C00002285
|
| D005889 | Gingival Recession |
C00002285
|
| D006099 | Granuloma |
C00002285
|
| D015745 | Granuloma, Foreign-Body |
C00002285
|
| D006103 | Granuloma, Lethal Midline |
C00002285
|
| D006130 | Growth Disorders |
C00002285
|
| D006311 | Hearing Disorders |
C00002285
|
| D034381 | Hearing Loss |
C00002285
|
| D006312 | Hearing Loss, Bilateral |
C00002285
|
| D006319 | Hearing Loss, Sensorineural |
C00002285
|
| D003639 | Hearing Loss, Sudden |
C00002285
|
| D016535 | Bronchial Hyperreactivity |
C00002285
|
| D006331 | Heart Diseases |
C00002285
|
| D006333 | Heart Failure |
C00002285
|
| D006344 | Heart Septal Defects, Atrial |
C00002285
|
| D006345 | Heart Septal Defects, Ventricular |
C00002285
|
| D006349 | Heart Valve Diseases |
C00002285
|
| D018883 | Heat Stroke |
C00002285
|
| D016481 | Helicobacter Infections |
C00002285
|
| D006406 | Hematoma |
C00002285
|
| D046748 | Hematoma, Epidural, Spinal |
C00002285
|
| D006408 | Hematoma, Subdural |
C00002285
|
| D020199 | Hematoma, Subdural, Acute |
C00002285
|
| D006417 | Hematuria |
C00002285
|
| D006463 | Hemolytic-Uremic Syndrome |
C00002285
|
| D006465 | Hemoperitoneum |
C00002285
|
| D006470 | Hemorrhage |
C00002285
|
| D020526 | Brain Stem Infarctions |
C00002285
|
| D006556 | Heroin Dependence |
C00002285
|
| D015658 | HIV Infections |
C00002285
|
| D019584 | Hot Flashes |
C00002285
|
| D006832 | Hydranencephaly |
C00002285
|
| D022124 | Hyperammonemia |
C00002285
|
| D006934 | Hypercalcemia |
C00002285
|
| D006947 | Hyperkalemia |
C00002285
|
| D006966 | Hyperprolactinemia |
C00002285
|
| D006974 | Hypertension, Malignant |
C00002285
|
| D001925 | Brain Damage, Chronic |
C00002285
|
| D020343 | Hypertensive Encephalopathy |
C00002285
|
| D017379 | Hypertrophy, Left Ventricular |
C00002285
|
| D006987 | Hypesthesia |
C00002285
|
| D006988 | Hyphema |
C00002285
|
| D001906 | Botulism |
C00002285
|
| D020514 | Hypokalemic Periodic Paralysis |
C00002285
|
| D007018 | Hypopituitarism |
C00002285
|
| D007037 | Hypothyroidism |
C00002285
|
| D002534 | Hypoxia, Brain |
C00002285
|
| D020925 | Hypoxia-Ischemia, Brain |
C00002285
|
| D017543 | Iliac Aneurysm |
C00002285
|
| D007154 | Immune System Diseases |
C00002285
|
| D007174 | Impulse Control Disorders |
C00002285
|
| D007232 | Infant, Newborn, Diseases |
C00002285
|
| D007235 | Infant, Premature, Diseases |
C00002285
|
| D007238 | Infarction |
C00002285
|
| D020762 | Infarction, Posterior Cerebral Artery |
C00002285
|
| D007239 | Infection |
C00002285
|
| D007415 | Intestinal Obstruction |
C00002285
|
| D020765 | Intracranial Arterial Diseases |
C00002285
|
| D001862 | Bone Resorption |
C00002285
|
| D020300 | Intracranial Hemorrhages |
C00002285
|
| D020767 | Intracranial Thrombosis |
C00002285
|
| D007431 | Intraoperative Complications |
C00002285
|
| D007443 | Intussusception |
C00002285
|
| D001847 | Bone Diseases |
C00002285
|
| D001791 | Blood Platelet Disorders |
C00002285
|
| D001766 | Blindness |
C00002285
|
| D001724 | Birth Weight |
C00002285
|
| D020145 | Basal Ganglia Hemorrhage |
C00002285
|
| D001480 | Basal Ganglia Diseases |
C00002285
|
| D007683 | Kidney Tubular Necrosis, Acute |
C00002285
|
| C536884 | Kleeblattschaedel syndrome |
C00002285
|
| D007759 | Labyrinth Diseases |
C00002285
|
| D007767 | Lacrimal Duct Obstruction |
C00002285
|
| D020144 | Basal Ganglia Cerebrovascular Disease |
C00002285
|
| D007818 | Laryngeal Diseases |
C00002285
|
| D007819 | Laryngeal Edema |
C00002285
|
| D014854 | Lateral Medullary Syndrome |
C00002285
|
| D053609 | Lethargy |
C00002285
|
| D007964 | Leukocytosis |
C00002285
|
| D056784 | Leukoencephalopathies |
C00002285
|
| D007968 | Leukoencephalopathy, Progressive Multifocal |
C00002285
|
| D001342 | Autonomic Nervous System Diseases |
C00002285
|
| D008047 | Lip Diseases |
C00002285
|
| D017093 | Liver Failure |
C00002285
|
| D001327 | Autoimmune Diseases |
C00002285
|
| D017116 | Low Back Pain |
C00002285
|
| D001284 | Atrophy |
C00002285
|
| D017563 | Lung Diseases, Interstitial |
C00002285
|
| D008180 | Lupus Erythematosus, Systemic |
C00002285
|
| D008275 | Magnesium Deficiency |
C00002285
|
| D008471 | Meconium Aspiration Syndrome |
C00002285
|
| D008478 | Mediastinal Emphysema |
C00002285
|
| D001282 | Atrial Flutter |
C00002285
|
| D008581 | Meningitis |
C00002285
|
| D001523 | Mental Disorders |
C00002285
|
| D019952 | Mental Disorders Diagnosed in Childhood |
C00002285
|
| C537347 | Mesenteric vascular disease |
C00002285
|
| D008641 | Mesenteric Vascular Occlusion |
C00002285
|
| D008831 | Microcephaly |
C00002285
|
| C538260 | Atresia of small intestine |
C00002285
|
| D008944 | Mitral Valve Insufficiency |
C00002285
|
| D020331 | Mobius Syndrome |
C00002285
|
| D020422 | Mononeuropathies |
C00002285
|
| D019964 | Mood Disorders |
C00002285
|
| D019957 | Motor Skills Disorders |
C00002285
|
| D009056 | Mouth Abnormalities |
C00002285
|
| D009059 | Mouth Diseases |
C00002285
|
| D001264 | Athetosis |
C00002285
|
| D009072 | Moyamoya Disease |
C00002285
|
| D009102 | Multiple Organ Failure |
C00002285
|
| D009120 | Muscle Cramp |
C00002285
|
| D009122 | Muscle Hypertonia |
C00002285
|
| D009128 | Muscle Spasticity |
C00002285
|
| D001249 | Asthma |
C00002285
|
| D009155 | Mutism |
C00002285
|
| D018771 | Arthralgia |
C00002285
|
| D017682 | Myocardial Stunning |
C00002285
|
| D009205 | Myocarditis |
C00002285
|
| D015508 | Nasal Obstruction |
C00002285
|
| D009357 | Neonatal Abstinence Syndrome |
C00002285
|
| D018218 | Neoplasms, Fibrous Tissue |
C00002285
|
| D009395 | Nephritis, Interstitial |
C00002285
|
| D001157 | Arterial Occlusive Diseases |
C00002285
|
| D009421 | Nervous System Malformations |
C00002285
|
| D001019 | Aortic Rupture |
C00002285
|
| D009459 | Neuroleptic Malignant Syndrome |
C00002285
|
| D009468 | Neuromuscular Diseases |
C00002285
|
| D009503 | Neutropenia |
C00002285
|
| D009667 | Nose Deformities, Acquired |
C00002285
|
| D009668 | Nose Diseases |
C00002285
|
| D001002 | Anuria |
C00002285
|
| D009771 | Obsessive-Compulsive Disorder |
C00002285
|
| D007752 | Obstetric Labor, Premature |
C00002285
|
| D015835 | Ocular Motility Disorders |
C00002285
|
| D000857 | Olfaction Disorders |
C00002285
|
| D009886 | Ophthalmoplegia |
C00002285
|
| D009901 | Optic Nerve Diseases |
C00002285
|
| D016155 | Oral Fistula |
C00002285
|
| D054517 | Orbital Cellulitis |
C00002285
|
| D009916 | Orbital Diseases |
C00002285
|
| D010014 | Osteolysis |
C00002285
|
| D010019 | Osteomyelitis |
C00002285
|
| D010020 | Osteonecrosis |
C00002285
|
| D000987 | Antisocial Personality Disorder |
C00002285
|
| D019867 | Anti-Glomerular Basement Membrane Disease |
C00002285
|
| D010195 | Pancreatitis |
C00002285
|
| D020759 | Anterior Spinal Artery Syndrome |
C00002285
|
| D015434 | Panniculitis |
C00002285
|
| D010211 | Papilledema |
C00002285
|
| D010254 | Paranasal Sinus Diseases |
C00002285
|
| D000799 | Angioedema |
C00002285
|
| D000789 | Angina, Unstable |
C00002285
|
| D000784 | Aneurysm, Dissecting |
C00002285
|
| D010439 | Peptic Ulcer Perforation |
C00002285
|
| D000783 | Aneurysm |
C00002285
|
| D018798 | Anemia, Iron-Deficiency |
C00002285
|
| D010538 | Peritonitis |
C00002285
|
| D010787 | Photosensitivity Disorders |
C00002285
|
| D010921 | Placenta Accreta |
C00002285
|
| D010922 | Placenta Diseases |
C00002285
|
| D000743 | Anemia, Hemolytic |
C00002285
|
| D011026 | Pneumopericardium |
C00002285
|
| D011030 | Pneumothorax |
C00002285
|
| D011045 | Poland Syndrome |
C00002285
|
| D000740 | Anemia |
C00002285
|
| D011248 | Pregnancy Complications |
C00002285
|
| D011249 | Pregnancy Complications, Cardiovascular |
C00002285
|
| D011250 | Pregnancy Complications, Hematologic |
C00002285
|
| D047928 | Premature Birth |
C00002285
|
| D049188 | Prenatal Injuries |
C00002285
|
| D011317 | Priapism |
C00002285
|
| D000707 | Anaphylaxis |
C00002285
|
| D000542 | Alveolitis, Extrinsic Allergic |
C00002285
|
| D000505 | Alopecia |
C00002285
|
| D017109 | Akathisia, Drug-Induced |
C00002285
|
| D015526 | AIDS Dementia Complex |
C00002285
|
| D011644 | Puerperal Disorders |
C00002285
|
| C536282 | Pulmonary arterial hypertension |
C00002285
|
| D011656 | Pulmonary Emphysema |
C00002285
|
| D054060 | Pulmonary Infarction |
C00002285
|
| D000380 | Agranulocytosis |
C00002285
|
| D000379 | Agoraphobia |
C00002285
|
| D011695 | Purpura, Schoenlein-Henoch |
C00002285
|
| D011697 | Purpura, Thrombotic Thrombocytopenic |
C00002285
|
| D020146 | Putaminal Hemorrhage |
C00002285
|
| D017511 | Pyoderma Gangrenosum |
C00002285
|
| D011782 | Quadriplegia |
C00002285
|
| D011928 | Raynaud Disease |
C00002285
|
| D019962 | Reactive Attachment Disorder |
C00002285
|
| D012019 | Reflex Sympathetic Dystrophy |
C00002285
|
| D012078 | Renal Artery Obstruction |
C00002285
|
| D051437 | Renal Insufficiency |
C00002285
|
| D000309 | Adrenal Insufficiency |
C00002285
|
| D012127 | Respiratory Distress Syndrome, Newborn |
C00002285
|
| D016156 | Respiratory Tract Fistula |
C00002285
|
| D015356 | Retinal Artery Occlusion |
C00002285
|
| D054058 | Acute Coronary Syndrome |
C00002285
|
| D012185 | Retroperitoneal Fibrosis |
C00002285
|
| D012206 | Rhabdomyolysis |
C00002285
|
| D012220 | Rhinitis |
C00002285
|
| D012559 | Schizophrenia |
C00002285
|
| D012595 | Scleroderma, Systemic |
C00002285
|
| D012607 | Scotoma |
C00002285
|
| D012652 | Self Mutilation |
C00002285
|
| D012678 | Sensation Disorders |
C00002285
|
| D012735 | Sexual Dysfunction, Physiological |
C00002285
|
| D020018 | Sexual Dysfunctions, Psychological |
C00002285
|
| D012769 | Shock |
C00002285
|
| D012770 | Shock, Cardiogenic |
C00002285
|
| D012797 | Sialometaplasia, Necrotizing |
C00002285
|
| D000137 | Acid-Base Imbalance |
C00002285
|
| D016170 | Accelerated Idioventricular Rhythm |
C00002285
|
| D012852 | Sinusitis |
C00002285
|
| D017445 | Skin Diseases, Vascular |
C00002285
|
| D012892 | Sleep Deprivation |
C00002285
|
| D000037 | Abruptio Placentae |
C00002285
|
| D000022 | Abortion, Spontaneous |
C00002285
|
| D000015 | Abnormalities, Multiple |
C00002285
|
| D013064 | Speech Disorders |
C00002285
|
| D020760 | Spinal Cord Ischemia |
C00002285
|
| D013159 | Splenic Infarction |
C00002285
|
| D000006 | Abdomen, Acute |
C00002285
|
| D009057 | Stomatognathic Diseases |
C00002285
|
| D013285 | Strabismus |
C00002285
|
| D020421 | Vagus Nerve Diseases |
C00002277
|
| D014607 | Uveomeningoencephalitic Syndrome |
C00002277
|
| D013352 | Subcutaneous Emphysema |
C00002285
|
| D014555 | Urination Disorders |
C00002277
|
| D053201 | Urinary Bladder, Overactive |
C00002277
|
| D013590 | Syphilis, Congenital |
C00002285
|
| D056647 | Systemic Vasculitis |
C00002285
|
| D054549 | Takotsubo Cardiomyopathy |
C00002285
|
| D013651 | Taste Disorders |
C00002285
|
| D013705 | Temporomandibular Joint Disorders |
C00002285
|
| D013706 | Temporomandibular Joint Dysfunction Syndrome |
C00002285
|
| D013611 | Tachycardia, Atrioventricular Nodal Reentry |
C00002277
|
| D013921 | Thrombocytopenia |
C00002285
|
| D013922 | Thrombocytosis |
C00002285
|
| D013923 | Thromboembolism |
C00002285
|
| D019851 | Thrombophilia |
C00002285
|
| D013924 | Thrombophlebitis |
C00002285
|
| D010437 | Peptic Ulcer |
C00002277
|
| D013981 | Tic Disorders |
C00002285
|
| D014077 | Tooth Erosion |
C00002285
|
| D014103 | Torticollis |
C00002285
|
| D014256 | Trichotillomania |
C00002285
|
| D014456 | Ulcer |
C00002285
|
| D014474 | Unconsciousness |
C00002285
|
| D038062 | Upper Extremity Deformities, Congenital |
C00002285
|
| D014525 | Urethral Stricture |
C00002285
|
| D062025 | Organophosphate Poisoning |
C00002277
|
| D016055 | Urinary Retention |
C00002285
|
| D014564 | Urogenital Abnormalities |
C00002285
|
| D014597 | Uterine Rupture |
C00002285
|
| D009216 | Myopia |
C00002277
|
| D014653 | Vascular Headaches |
C00002285
|
| D054079 | Vascular Malformations |
C00002285
|
| D009140 | Musculoskeletal Diseases |
C00002277
|
| D020293 | Vasculitis, Central Nervous System |
C00002285
|
| D020301 | Vasospasm, Intracranial |
C00002285
|
| D014689 | Venous Insufficiency |
C00002285
|
| D020246 | VENOUS THROMBOSIS |
C00002285
|
| D018754 | Ventricular Dysfunction |
C00002285
|
| D018487 | Ventricular Dysfunction, Left |
C00002285
|
| D014715 | Vertebrobasilar Insufficiency |
C00002285
|
| D014890 | Wegener Granulomatosis |
C00002285
|
| D015877 | Miosis |
C00002277
|
| D004827 | Epilepsy |
C00002277
|
| C537948 | Ceroid lipofuscinosis, neuronal 1, infantile |
C00007256
|
| D000140 | Acidosis, Lactic |
C00000208
|
| D004831 | Epilepsies, Myoclonic |
C00002277
|
| D000550 | Amblyopia |
C00000208
|
| D000749 | Anemia, Megaloblastic |
C00000208
|
| D002340 | Carotid Artery Diseases |
C00000208
|
| D002386 | Cataract |
C00000208
|
| D002418 | Cattle Diseases |
C00000208
|
| D002779 | Cholestasis |
C00000208
|
| D002780 | Cholestasis, Intrahepatic |
C00000208
|
| D043171 | Chromosomal Instability |
C00000208
|
| D003920 | Diabetes Mellitus |
C00000208
|
| D003925 | Diabetic Angiopathies |
C00000208
|
| D050171 | Dyslipidemias |
C00000208
|
| D004415 | Dyspepsia |
C00000208
|
| D019446 | Endotoxemia |
C00000208
|
| D004381 | Duodenal Ulcer |
C00002277
|
| D006259 | Craniocerebral Trauma |
C00002277
|
| D005923 | Glomerulosclerosis, Focal Segmental |
C00000208
|
| D018149 | Glucose Intolerance |
C00000208
|
| D006073 | Gout |
C00000208
|
| D006505 | Hepatitis |
C00000208
|
| D002385 | Cataplexy |
C00002277
|
| D020138 | HYPERHOMOCYSTEINEMIA |
C00000208
|
| D006950 | Hyperlipidemia, Familial Combined |
C00000208
|
| D006949 | Hyperlipidemias |
C00000208
|
| D001146 | Arrhythmia, Sinus |
C00002277
|
| D006938 | Hyperlipoproteinemia Type II |
C00000208
|
| D006952 | Hyperlipoproteinemia Type III |
C00000208
|
| D006954 | Hyperlipoproteinemia Type V |
C00000208
|
| D000855 | Anorexia |
C00002277
|
| D020236 | Amnesia, Transient Global |
C00002277
|
| D014062 | Tongue Neoplasms |
C00002020
|
| D007009 | Hypolipoproteinemias |
C00000208
|
| D020244 | Infarction, Middle Cerebral Artery |
C00000208
|
| D011470 | Prostatic Hyperplasia |
C00002020
|
| D007662 | Ketosis |
C00000208
|
| D007938 | Leukemia |
C00000208
|
| D015470 | Leukemia, Myeloid, Acute |
C00000208
|
| D008060 | Lipodystrophy |
C00000208
|
| D020734 | Parkinsonian Disorders |
C00002020
|
| D008269 | Macular Edema |
C00000208
|
| D047508 | Massive Hepatic Necrosis |
C00000208
|
| D024821 | Metabolic Syndrome X |
C00000208
|
| D010212 | Papilloma |
C00002020
|
| D009798 | Ocular Hypertension |
C00000208
|
| D010383 | Pellagra |
C00000208
|
| D009914 | Oral Submucous Fibrosis |
C00002020
|
| D010612 | Pharyngitis |
C00000208
|
| D009062 | Mouth Neoplasms |
C00002020
|
| D012162 | Retinal Degeneration |
C00000208
|
| D012817 | Signs and Symptoms, Digestive |
C00000208
|
| D012859 | Sjogren's Syndrome |
C00000208
|
| D012871 | Skin Diseases |
C00000208
|
| D012877 | Skin Manifestations |
C00000208
|
| D016135 | Spinal Dysraphism |
C00000208
|
| D018781 | Tension-Type Headache |
C00000208
|
| D014098 | Toothache |
C00000208
|
| D014947 | Wounds and Injuries |
C00000208
|
| D007516 | Adenoma, Islet Cell |
C00000209
|
| D020520 | Brain Infarction |
C00000209
|
| D003921 | Diabetes Mellitus, Experimental |
C00000209
|
| D007153 | Immunologic Deficiency Syndromes |
C00002020
|
| D007680 | Kidney Neoplasms |
C00000209
|
| D002280 | Carcinoma, Basal Cell |
C00002020
|
| D010391 | Pemphigoid, Bullous |
C00000209
|
| D012393 | Rosacea |
C00000209
|
| D000405 | Akinetic Mutism |
C00002057
|
| D000437 | Alcoholism |
C00002057
|
| D000860 | Anoxia |
C00002057
|
| D001176 | Arthrogryposis |
C00002057
|
| D002114 | Calcinosis |
C00002057
|
| D002289 | Carcinoma, Non-Small-Cell Lung |
C00002057
|
| D002294 | Carcinoma, Squamous Cell |
C00002057
|
| D018290 | Cervical Intraepithelial Neoplasia |
C00002057
|
| D003093 | Colitis, Ulcerative |
C00002057
|
| D003110 | Colonic Neoplasms |
C00002057
|
| D019955 | Conduct Disorder |
C00002057
|
| D003490 | Cyanosis |
C00002057
|
| D003865 | Depressive Disorder, Major |
C00002057
|
| D003872 | Dermatitis |
C00002057
|
| D003928 | Diabetic Nephropathies |
C00002057
|
| D020821 | Dystonic Disorders |
C00002057
|
| D001068 | Eating Disorders |
C00002057
|
| D004802 | Eosinophilia |
C00002057
|
| D005921 | Glomerulonephritis |
C00002057
|
| D044882 | Glucose Metabolism Disorders |
C00002057
|
| D006258 | Head and Neck Neoplasms |
C00002057
|
| D006606 | Hiccup |
C00002057
|
| D006930 | Hyperalgesia |
C00002057
|
| D006984 | Hypertrophy |
C00002057
|
| D006985 | Hyperventilation |
C00002057
|
| D007246 | Infertility |
C00002057
|
| D055959 | Intervertebral Disc Degeneration |
C00002057
|
| D008107 | Liver Diseases |
C00002057
|
| D008175 | Lung Neoplasms |
C00002057
|
| D008545 | Melanoma |
C00002057
|
| D028361 | Mitochondrial Diseases |
C00002057
|
| D002277 | Carcinoma |
C00002020
|
| D020267 | MPTP Poisoning |
C00002057
|
| D009361 | Neoplasm Invasiveness |
C00002057
|
| D009362 | Neoplasm Metastasis |
C00002057
|
| D009389 | Neovascularization, Pathologic |
C00002057
|
| D054081 | Neuronal Migration Disorders |
C00002057
|
| D009759 | Nystagmus, Pathologic |
C00002057
|
| D009765 | Obesity |
C00002057
|
| D009845 | Oligospermia |
C00002057
|
| D010182 | Pancreatic Diseases |
C00002057
|
| D030361 | Papillomavirus Infections |
C00002057
|
| D010302 | Parkinson Disease, Secondary |
C00002057
|
| D003668 | Pressure Ulcer |
C00002057
|
| D051436 | Renal Insufficiency, Chronic |
C00002057
|
| D015619 | Respiratory System Abnormalities |
C00002057
|
| D012878 | Skin Neoplasms |
C00002057
|
| D055752 | Small Cell Lung Carcinoma |
C00002057
|
| D016137 | Spina Bifida Cystica |
C00002057
|
| D013117 | Spinal Cord Compression |
C00002057
|
| D013274 | Stomach Neoplasms |
C00002057
|
| D020323 | Tics |
C00002057
|
| 188890 | TOBACCO ADDICTION, SUSCEPTIBILITY TO |
C00002057
|
| D014029 | Tobacco Use Disorder |
C00002057
|
| D018901 | Peroxisomal Disorders |
C00001387
|
| D014133 | Tracheal Diseases |
C00002057
|
| D001745 | Urinary Bladder Diseases |
C00002057
|
| D018366 | Vasculitis, Leukocytoclastic, Cutaneous |
C00002057
|
| D018879 | Ventricular Premature Complexes |
C00002057
|
| D015430 | Weight Gain |
C00002057
|
| D020324 | Amnesia, Anterograde |
C00002292
|
| D000648 | Amnesia, Retrograde |
C00002292
|
| D001072 | Apraxias |
C00002292
|
| D003704 | Dementia |
C00002292
|
| D015352 | Dry Eye Syndromes |
C00002292
|
| D004401 | Dysarthria |
C00002292
|
| D004948 | Esotropia |
C00002292
|
| D007638 | Keratoconjunctivitis Sicca |
C00002292
|
| D008103 | Liver Cirrhosis |
C00002292
|
| D020326 | Migraine without Aura |
C00002292
|
| D009293 | Opioid-Related Disorders |
C00002292
|
| D020795 | Photophobia |
C00002292
|
| D014985 | Xerophthalmia |
C00002292
|